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prednisolone-treatment sessions are graphed
to the right of each dotted line. For each
day, circles indicate pre-injection sessions
and triangles indicate post-injection sessions •••• 135
23. The effects of repeated, daily prednisolone
(0,8,16 and 32 mg/kg, IM) (N=3/dose group)
upon acquisition of Sidman avoidance (S-S =
2.0"1 R-S = 20.0"1 shock duration = 0.5"1
amplitude = 0.8 mAmp) programmed for a shuttle-box. Subjects were assigned to the various dose groups, treated for five consecutive
days, then exposed to Sidman avoidance sessions (30 minutes each) for the ensuing 10
days. Data are plotted as average number of
responses, shock-to-shock intervals, and
response-to-shock intervals taken by each
groups across the ten days of contingency
exposure •••••••••••••••••••••••••••••••••••••••••• 146
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CHAPTER I
GENERAL INTRODUCTION
Prednisolone and other synthetic glucocorticoids
are employed at high doses and for prolonged periods in
the treatment of acute lymphocytic leukemia, lymphomas,
certain carcinomas of the breast, and·miscellaneous
solid tumors (Guynn,

1979~

Livingston & Carter, 1970).

However, patients receiving chemotherapy combinations
which include glucocorticoids have experienced high
rates of behavioral abnormalities (Porkoff, Silber,
Tyler, Cartwright, & Wintrobe,
Benjamin, 1979).

1959~

Stewart and

Various evidence suggests that high

levels of circulating glucocorticoids, whether caused by
endogenous or iatrogenic factors, predispose patients to
psychiatric complications (Guynn,
Melman,
1979~

1974~

1979~

Ling, Perry, and Tsuang,

Liddle and
1981~

Smith, Barish, Correa, and Williams,

and Mawhinney, 1973).

Nelson,

1972~

Thomas

It is thus plausible that gluco-

corticoids contribute substantially to the high incidence of behavioral abnormalities in chemotherapy
recipients.
In glucocorticoid-treated patients, a large variety
of behavioral disorders have been observed.

Marked al-

terations have been reported in consummatory behavior

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2

(Tepperman, 1980) , motor

activi~y

(Stewart and Benjamin,

1979) weight (Haynes & Murad, 1980), sleep (Guynn,
1979), and
others.

affec~

(Ling, Perry, & Tsuang, 1981), among

Prolonged glucocorticoid therapy may impair

functioning of the pituitary-adrenal axis through negative feedback mechanisms (Guynn, 1979; Haynes & Murad,
1980), induce a characteristic 'steroid myopathyi with
associated weakness and fatigability (Pearson, 1974),
and alter various aspects of the sensorium (Guynn,
1979).

Further, such behavioral dysfunctions appear

protean, thus resulting in increased difficulties of
diagnosis (Guynn, 1979).
At present, which individuals will display behavioral sequelae, as well as which reactions will manifest, remain unpredictable (Ling, Perry, & Tsuang,
1981).

This lack of prediction may relate to the large

number of factors simultaneously acting upon the chronically ill patient.

Such glucocorticoid-recipients are

likely to be receiving multiple chemical agents, experiencing direct and/or indirect neuropsychiatric complications from the disease process itself, possess a
changing interpersonal milieu, and may be having marked
psychological reactions to the
(Guynn, 1979) •

diseas~'s

prognosis

The mechanism by which the glu-

cocorticoids induce behavioral disturbances is still
largely unknown (Ling, Perry, & Tsuang, 1981).
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Glucocorticoid-induced behavioral sequelae were
thus judged as worthy of further analysis.

The per-

formance of laboratory rats in several simple tests was
selected as an assay battery with which to assess the
effects of prednisolone, a commonly used synthetic
glucocorticoid.

It was reasoned that if such behavioral

sequelae could be routinely produced in a laboratory
model, then identification of mechanisms of behavioral
action, selective antagonists, and adverse behavioral
drug interactions might be expedited.
Specifically then, a series of thirteen behavioral
toxicology and behavioral pharmacology experiments were
conducted to analyze the impact that various repeated
and acute prednisolone treatments might have on selected
behavioral endpoints.

Selection of these endpoints was

done by perusal of several volumes of each of the following journals:

Pharmacology, Biochemistry and

Behavior, Psychopharmacology, Physiology and Behavior,
Hormones and Behavior, Journal of Comparative and Physiological Psychology, and Neuroscience and Biobehavioral
Reyiews.

Examination of such journals, as well as in-

spection of such standard texts as Seiden and Dykstra
(1977), clearly revealed a general dichotomy of research
styles found for the study of chemical - behavior relationships.

The first style is by far the more tradi-

tional - having come largely from biology, pharmacology
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and toxicology.

It emphasizes the use of more rudiment-

ary, more primordial, largely non-operant response

sy:~

tems (e.g. activity, feeding, nocioception), wherein the
involvement of learning mechanisms appears to have been
minimized.

Behaviors within this set have been studied

largely in group designs, which have employed large·N's.
The chemicals have been administered in repeated, even
chronic, treatment regimens and often for the examination of relatively irreversible effects.

Relatively few

behavioral observations have been made per subject, and
in very short sessions at that.

Very little time and

resource has been invested in the behavioral training of
each subject.

There has existed relatively little tech-

nical control over the moment-to- moment occurrence of
behavior, and perhaps as a result, there has existed a
great deal of variability both between and within subjects.

As such, statistical control over variability

has been required-as a part of the 'proof' process.
More recently, various of these behavioral measures have
found their way into the budding field termed behavioral
toxicology.
The second style employs various assays which explicitly involve the study of chemical interventions
upon either an already-acquired response, or alternately, upon an ongoing learning process.

These behaviors

have for the last 30 years made up the endpoints of the
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experimental analysis of behavior.

Behaviors of this

second set have been increasingly studied in singlesubject designs, and have typically been examined in
very low N experiments.

The chemical interventions

themselves have typically been acute-- with each subject
receiving all levels of the independent variable.

Al-

most of necessity for this type of research design, the
effects of the independent variable have been highly
reversible.

This style has emphasized a considerable

investment of time and resource into the behavioral development of each subject under study.

In addition,

multiple behavioral measurements have been made for each
subject, with an attendant high degree of technical control over the moment-to-moment likelihood of the response.

This practice has decreased within-subject var-

iabilities considerably and has led practitioners of
this style away from the use of statistics for the control of variability and use in proof.

In recent years,

this later set of behavioral measures and practices has
found its way into the budding field of behavioral pharmacology.

It should be emphasized, however, that these

distinctions are to some extent arbitrary as there has
occurred considerable overlap of style in some quarters
as given drug-behavior-environment issues have dictated.
For purposes of the present research, then, it was
felt that the most desirable pedagogical as well as
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scientific strategy would be to analyze prednisolone's
behavior effects by employing both strategies.

As such,

Experiment nos. 1-3 in many ways characterize the first
style of research described above--the style having
become known as behavioral toxicology.

Experiment nos.

4-13, on the other hand, in many ways characterize the
second style of research described above--the style
having become known as behavioral pharmacology.

Thus,

both acute and chronic drug influences were examined on
a range of behaviors which included both learned and
unlearned response repertoires.

To some extent, there

also occurred a degree of blending.

For instance,

Experiment no. 3 concerned conditioned taste aversion a learned response - but the experiment in many other
ways represents the first style of research.

A second

counter-example is taken from Experiment no. 13 wherein
the learning of unsignalled avoidance was the behavioral
endpoint yet the study was conducted in a group design
which employed repeated drug treatments.

Yet a third

counter-example ·involves Experiment no. 2 wherein the
style was very much in the toxicology tradition, yet
wheel running activity was assayed repeatedly for all
subjects.

It was hoped that by employing a range of

methods a profile might emerge of the behavioral effects
of the glucocorticoid prednisolone.
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CHAPTER II
EXPERilvlENT I: EFFECTS OF REPEATED PREDNISOLONE
TREATMENT ON BODY 1 ADRENAL AND TESTES WEIGHTS 1 WATER
INTAKE, LOCOMOTION, NOCIOCEPTION AND GRASPING RESPONSES
IN WEANLING MALE RATS.
Introduction
Various authors have suggested ·that acute glucocorticoid treatment, even if given at high doses, is
unlikely to yield physiological disruption.

Rather,

deleterious effects are more commonly seen only after
the subject has been
stance.

re~8atedly

challenged with the sub-

As such, Experiment no. 1 employed a repeated

treatments regimen in hopes of maximizing prednisolone's
behavioral influence.

Further, while clinical reports

of adverse psychiatric reactions to glucocorticoids have
been many, which particular response systems might be
the most likely to be impacted upon has remained somewhat unclear.

Therefore, for the first experiment a

battery of tests was adopted to examine a range of rodent

behav~oral

function--a strategy which previously

has worked well to document selective behavioral drug
effects (e.g. Nanry, Sewell, Gallus, Vanecek, and
Poling, 1983).

These assessments included a measure of

appetitive behavior (water consumption) , two measures of
motor function (wheel running and the grasping
7
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response) , and a measure of sensory function (hot plate
assay of nocioception) •

In addition, daily measures of

body weight change, along with final measures of adrenal
and gonadal weight, were taken as assessments of overall
drug toxicity.

Both water intake and body weight meas-

ures were taken on a daily basis to document the general
course of behavioral and physiological change under repeated prednisolone treatment.

Weanling rats were se-

lected as research subjects so as to maximize the likelihood of toxicity becoming apparent.

It has been re-

ported, for instance, that glucocorticoids can abate
growth, produce muscle wasting, and suppress pituitaryadrenal function.
Method
Subjects
Twenty-four male Sprague-Dawley rats, 33-35 days of age,
and bred and raised in the laboratory's colony, served
as subjects.

Rapidly growing rats were selected in an

effort to maximize potential evidence of systematic toxicity.

Subjec~s

temperature (23°

were individually housed under constant

c, ca) and illumination.

P~rina

Labor-

atory Chow (Rat Chow 5012, Ralston-Purina Co., St.
Louis, MO) and water were continuously available for all
subjects.
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Apparatus
Water Intake Monitors
Water intake was measured via modified 50-ml
disposable syringes functioning as fluid reservoirs
. (Becton-Dickinson, Rutherford, N.J.: model iBect-5605).
The syringe barrels, with plungers removed, were plugged
with no. 5 rubber stoppers and associated drinking
spouts, and were then occluded at the needle end by
heating.

These reservoirs were subsequently filled with

water, inverted, and attached to individual, stainless
steel cages (32cm x 24cm x 20 em: Unifab Corp.,
Kalamazoo, MI).
Total Body Weights
Individual body weights were determined daily with
a top-loading scale (Pelouze, Model 1000, Pelouze Co.,
Evanston, IL) •
Locomotion
·~

Motor activity was measured for each subject's per-

formance on one of three standard Wahmann Running Wheels
. (Wahmann Co., Baltimore, MD).·

Each wheel (35cm dia. x

llcm wide) was equipped with a microswitch which electronically sensed revolutions of both directions.
Running wheels were placed in separate,
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sound-attenuating chambers (6lcm x 61cm x 61cm) equipped
with masking white noise (80 db), forced air
ventilation, and illumination (7.5 volt, G.E.).
Nocioception
An electrically heated metal floor (63cm x 16cm x
9.5cm~

model #26000, Chicago Surgical and Electrical

Co., Chicago, IL) surrounded by three wooden walls
(2l.Scm x 63cm x 2.0cm) and a fourth transparent acrylic
wall (21.5cm x 63cm x 0.6cm) served.
heated to 59°

c, ca.

The floor was

Latencies to hind paw-lick were

assessed by an observer who terminated a running time
meter upon each occurrence of the behavior.
Grasping response
Subjects were suspended by forepaw-grasp from a
O.Ol3cm dia. wire, 43cm above the floor.

Latencies from

the moment of grasping to the release of the grasp were
assessed by an observer who operated a running time
meter.
Adrenal and Gonad Weights
Excised glands were weighed on a Mettler H54 Analytical
Balance (Mettler Co., Switzerland).
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Procedure
Water Intake and Body Weight Measurements
Water intake was monitored by noting net changes in
milliliters absent from fluid reservoirs over 20 consecutive 24-hour periods.

At the end of each 24-hour per-

iod, reservoirs were emptied and then re-filled with
fresh water.

An initial 8-day acclimation period to

this procedure occurred.

Subsequently, twelve daily

body weight assessments and intramuscular injections
were performed for each subject at the time of intake
measurement.
Locomotion, Grasping Response, and Nocioception
After twelve days of injections, a series of behavioral tests were performed with each rat.

Subjects

were injected and thirty minutes later were placed in
running wheels for an additional 30 minutes.

Immediate-

ly after this, the grasping response tests were conducted.

In this assay, each subject was moved manually in a

vertical downward direction; the wire to be grasped was
positioned immediately in front of the subject.

When

the subject grasped the wire, the animal was released
and was thus suspended by the forepaws.

Latencies, from

this moment until the subject dropped from the wire,
were recorded.

One-minute intervals occurred between
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trials.

Five such trials, conducted in succession for

each subject, occurred.

Trials were restricted to 3.0

minutes at maximum.
Following completion of the grasping response assessment, each subject was studied in the hot-plate
analgesia test.

Latencies to hind paw-lick were anal-

yzed by exposing each subject to five trials, each of a
maximum 30-second duration, and separated by inter-trial
intervals of 2.0 minutes.

As a subject was placed on

the hot-plate, a running time meter was concurrently
activated7 when the subject licked either of its hindpaws, the meter was switched off.
Organ Weights
Following completion of behavioral tests on Day 12
of study, subjects were sacrificed under deep ether anesthesia1 adrenal and gonadal glands then being excised
and weighed in pairs for each animal.

The weights of

the organ pairs were reported as single units and as
units relative to the body weights on Day 12.
Drug Preparation and Administration
Stock suspensions of prednisolone

~cetate

(SO

mg/ml) (Carter-Glogan, Glendale, AZ) were diluted with
physiological saline to concentrations of

a.o,

16.0,

32.0 mg/ml and administered at 1.0 ml/kg volumes by
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intramuscular injections. ·Dosage levels of 0.0, 8.0,
16.0, and 32.0 mg/kg were employed with four groups of
subjects (N=6/group) each receiving one.

This dose

range was selected by reference to previous prednisolone
studies which used rat subjects (e.g. Moore and Hoult,
19807 Sanders, Johns, Eldetraw, & Cobb, 1977).

All

injections occurred at the beginning of the 24- hour
water intake periods, and 30 minutes before exposure to
the wheel running apparatus on the day of acute behavioral tests (Drug Day 12).
Statistical Analysis
Daily water intake and body weight data, and the
results of the grasping response and nocioception
assays, were analyzed by use of repeated measures
analysis of variance (Hayes, 1963).

Prednisolone

effects upon adrenal, gonadal, and body weights (Day
12), relative glandular weights, and locomotion were
assessed by one-way analysis of variance (ANOVA) techniques.
Tu~ey

Analysis of variance tests were followed by

Simultaneous Testing procedures and Least

Significant Difference Tests (Hayes, 1963).

Assay

results were reported graphically as group means. ±
standard errors (N=6/group).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14

Results
Prednisolone Effects on Water Intake
Daily administrations of prednisolone acetate produced a general decrease in water intake at all dose
levels ex- amined, as compared to control intake.

As

shown in Figure 1, water intake for saline-treated
subjects demonstrated relative stability, while the
intake of drug-treated groups showed a progressive
decay.

Two-way repeated measures ANOVA indicated that

there were significant effects regarding dosage level
(f= 8.914, df.= 9/216, p<0.001), and of a dose by treatments interaction (f= 3.745, df= 27/216, p<0.001).

For

higher dose groups (16.0 and 32.0 mg/kg), a partial
recovery of water intake occurred during latter
sessions.
Prednisolone Effects on Body Weight
In addition, daily prednisolone treatments produced
clear indications of accruing, dose-related, systemic
toxicities as evidenced by progressive loss in total
body mass.

These effects are displayed in Figure 2

where mean number of grams change (X±S.E.) from baseline
body weights is plotted as a function of number of days
of drug treatment for each dose group.

Thus, whereas

the saline-treated subjects gained 66.7 ± 5.5. gm; and.
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Figure 1. The Effects of Daily Prednisolone Treatments
Upon Number of Milliliters of Water Intake per
Day.

'Day 1' Entitles the Mean Number of

Milliliters Consumed Over the Last 3 Days of
the Baseline Period.

For All Subsequent Data

Points, Drug Injections Occurred Immediately
Before Each 24-hour Observation Period.

Each

Point Represents a Group Mean ± Standard Error
(N=6/Group).
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the 32.0 mg/kg group lost 56.3 ± 5.2 gm.

A two-way

repeated measures ANOVA indicated a highly significant
main effect of dosage level (f= 5.691, df= 11/264, p(
0.001), and a significant dose x treatments interaction
(f= 52.419, df= 33/220, p(0.001).

The dose effect func-

tion relating dosage of prednisolone to Day 12 body
weight is displayed graphically in Figure 4 with an N of
6 per group.

One-way ANOVA indicated these differences

to be significant (f= 125.515, df= 3/20, p(0.001).
Prednisolone Effects on Organ Weights
Figure 3 presents the effects of dose of drug
treatment upon the·absolute and relative weights for
excised pairs of adrenals and gonads.

The 32.0 mg/kg

group was judged as too debilitated at Drug Day 12 for
further analysis; thus organ weights and Day 12 behavioral tests were omitted for those subjects.

A

one-way ANOVA procedure assessing average absolute
weights of paired adrenal glands across groups indicated
these results to be significantly different across
grQups (f= 119.625, df= 2/15, p(O.OOl).

The Tukey Si-

multaneous Testing procedure demonstrated that it was
the saline-treated subjects which differed significantly
(p(O.OOl).

The adrenal-to-body weight (mg/kg) ratios

also demonstrated clear effects of drug dosage level.
The one-way ANOVA procedure showed these results to
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Figure 2. The Effects of Daily Prednisolone Administrations Upon Average Changes in Body Mass Across
Treatment Groups.

'Pre' Entitles that Base-

Line from which All Weight Changes are Calculated.

Each Subsequent Weight Determination

Follows by 24-hours the Preceding Injection.
Each Data Point (Days 1-11) is a·Group Mean±
Standard Error (N=6/Group).
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differ significantly (f= 41.662, df= 2/15, p(0.001).

As

displayed in Figure 3, these results indicated that as
dose increased the adrenal glands atrophied at a higher
rate than that which was experienced by the body
overall.
As shown in Figure 3, gonads like adrenals, decreased further in absolute weight as the dose of prednisolone increased.

One-way ANOVA procedures indicated

these effects to be significantly different (f= 17.163,
df= 2/15, p(0.001).

The Tukey Simultaneous Testing pro-

cedure further showed saline-treated subjects' testes to
weigh more than 8.0 mg/kg group's gonads (p(0.05) and
those of the 16.0 mg/kg treatment (p(0.01), while the
8.0 mg/kg group's glands weighed more than those of the
16.0 mg/kg group (p(0.05).

Inspection of relative gon-

adal weights [testes (qm) to total body weight (qm)]
indicated that as dosages increased, the relative gonadal weights also increased.

The average relative gonadal

weight ratios across the 0.0, 8.0, and 16.0 mg/kg groups
were significantly different (one-way ANOVA: f= 21.149,
df~

2/15, p<0.001), with the saline group differing from

both the 8.0 and 16.0 mg/kg subjects (Tukey: p(O.Ol in
both cases).

The most influential determinant of the

direct nature of the relationship between dose and
gonad-to-body weight ratios is to be noted by inspection
of Figures 2 and 3.

The two collectively reveal that
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Figure 3. The Effects of Dose of Twelve Daily Prednisolone Treatments upon Both Absolute and Rela- ·
tive, Adrenal and Gonadal Weights.

Each Data

Point is a Group Mean ± Standard Error
(N=6/Group).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22

en

t=-

:I:

(.!)

-

0

LaJ

0

z

i=
<t
a:
3:

a::
c

'0

(X)

3:
_J

<t

<D

-

q

CD

LaJ

<(

<(

w
0

d

z

0

_.J

0

-z

(J)

0

d

~

0

d

0

.C)

N

SW'1~E>I"l11~ Nl lHE>I3M

0

,.,0

2

gOI

X

c

w

0

a:

0

0..

MS/0'1

LL.

0

-U)

(/)

t--

J:

Q

-w

(.!)

<("

CD

·Z

'0

0

(.!)

0

d

(.!)

0

~

SW\1~9

0

ai

3:

0.

0

0

0

Nl !H913M

w
en
0

~
a::

3:

0

0

0001

X

M8/Q9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

c

23

total body mass decayed more quickly than gonads, per
se.

These results with gonads contrast with the oppo-

site results involving adrenal-to-body ratios.

By

comparing relative adrenal to relative gonad weights
across dosage groups, it is evident that the adrenals
sustained specific degeneration when compared to both
another endocrine gland, and general body mass.
Prednisolone Effects on Locomotion, Grasping Response,
and Nocioception
Assays

o~

locomotor activity, grasping responses,

and analgesia were conducted on the twelfth day of study
for all subjects, except the 32.0 mg/kg groups as previously noted.

The results of these three assays are

presented in Figure 4.

Locomotor performances in 30-

minute running wheel sessions were assessed using oneway ANOVA procedures and these results were found to
approach, but not reach, statistical significance (f=
2.338, df= 2/15, p(0.131).

Marked variability within

groups bore a direct relation to this lack of significance.

Visual observation of subjects in the home cages

revealed, however, a seemingly dose-related increase in
ambu1ation and 'darting', and an overall 'frenetic'
appearance. Evaluation of the grasping response revealed
significant dose-related increases in the latency to
release grasp of the wire (two-way repeated measures
ANOVA, effect of drug dose:

f= 5.583, df= 2/17, p( ·
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Figure 4. The

Effe~ts

of Dose of Twelve Daily Predniso-

lone Treatments Upon Four Serial Assays:

30-

Minute Wheel Running; Grasp-Release Measure;
Hot-Plate Analgesia Assay; and Body Weights on
Day 12.

Each Data Point Represents a Group

Mean ± Standard Error (N=6/Group) •
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0.015).

However, there was no effect as a function of

number of trials (f= 1.546, df= 3/72, p(0.161) or of a
dose by trials interaction (f= 1.546, df= 8/60, p(
0.161).

The effects of drug dose upon latency to drop

are presented graphically for the 0.0, 8.0, and 16.0
mg/kg groups (N=6/group) in Figure 4.
Results of the assessment of nocioception by use of
the hot-plate method are presented in Figure 4.

Two-way

repeated measures ANOVA showed that the main effect of
dosage level approached but did not reach statistical
significance (f= 0.376, df= 4/72, p<O.llO).

No effects

of either the number of trials (f= 0.376, df= 4/72, p<
0.825) or of an interaction between dosage and trial
number (f= 0.753, df= 8/60, p<0.645) were observed.
Discussion
Experiment no. 1 clearly demonstrated several important points.

First, prednisolone was found to be

behaviorally active in several of the assays employed.
Clear effects were found for water intake and for the
gr~sping

response, while trends toward significance were

also found for the hot-plate measure of nocioception and
the wheel running measure of locomotor activity.

Thus,

the results of Experiment no. 1 did generally corroborate the frequent clinical impression that glucocorticoid
treatment is psychiatrically active.

In addition,
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Experiment no. 1 suggested that the assays which were
used might be of considerable utility in further
exploration of prednisolone's behavioral effects. That
water balance was markedly altered is of some significance since various other of the glucocorticoids
have been found to clearly influence sodium balance.

It

is likely that a similar type of effect was operative
here, and helps to account for .the large depressions in
water intake.

Depressed water consumption could also

have contributed to the dramatic body weight decrements.
The body weight changes, however, were probably
exascerbated by the well- known impact of
glucocorticoids on a wide range metabolic processes particularly those related to glucose metabolism.

These

issues are discussed at length.in the General Discussion
section.
A number of ambiguities remained at the completion
of Experiment no. 1.

First, it was unclear as to

whether these types of effects could be obtained in
females, and also, whether these could be obtained in
adult subjects rather than rapidly growing animals.
Second, while the literature suggests that prednisolone,
as a glucocorticoid, is likely to yield a·marked
elevation in· blood glucose levels, this fact remained to
be demonstrated in those same subjects which were evidencing marked behavioral alterations.

This demon-

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

28

stration would be required if a glucose-mediation
hypothesis is to be considered tenable regarding prednisolone's behavioral influence.

Third, it remained

unclear as to why prednisolone's effect on wheel running
was so modest, indeed, statistically not significant.
Given that (1) the animals appeared so 'frenetic': (2)
that numerous clinical· reports have detailed psychomotor
agitation

in glucocorticoid-treated patients: and (3)

that other studies employing rodents have detailed
glucocorticoid-induced psychomotor activity enhancements, it was expected that prednisolone would have
produced dose-related enhancements in wheel- running activity.

It is plausible that the only reason for the

negative locomotion results in Experiment no. 1 is that
only a single running wheel test session was conducted.
Not only might this technique contribute to an inordinate level of variability, but also, drug treatments
might conceivably interact with number of exposures to
the testing environment to determine activity outcomes.
For these reasons, Experiment no. 2 was initiated, and
employed a methodology very similar to that used in
Experiment no. 1.
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CHAPTER III
EXPERIMENT II: EFFECTS OF REPEATED PREDNISOLONE
TREATMENT ON BODY, ADRENAL AND KIDNEY WEIGHTS, WATER
INTAKE, MURICIDE, PLASMA GLUCOSE, AND LOCOMOTION IN
WHEEL-RUNNING SESSIONS CONDUCTED DAILY, IN ADULT FEMALE
RATS.
Introduction
Experiment no. 1 examined sequelae of repeated
prednisolone treatments, using weanling male rats.

In

that study prednisolone influences on body weight, water
intake, adrenal and testicular weights, nocioception,
grasping responses, and locomotion were explored.

While

various measures demonstrated clear prednisolone effects, the locomotion assay yielded an ambiguous result.
Subjects had received 12 daily treatments, at one of
four assigned doses (0.0, 8.0, 16.0 and 32.0 mg/kg).
Thirty-minutes after the twelfth administration, subjects were tested in a 30-minute wheel-running session.
Data relating prednisolone dose to running wheel revolutions showed a direct, linear relationship which
approached, but did not reach, statistical significance.
This lack of effect is unexpected for three reasons.
First, various clinical reports have discussed "steroid
psychosis" and have detailed psychomotor agitation in
glucocorticoid-treated patients (e.g. Brown, 1962:
Guynn, 1979: Haynes and Murad, 1980).

Second, non-

29
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systematic inspection of Experiment no. 1 subjects in
home cages suggested a seeming dose-related increase in
ambulation and 'darting', and an overall 'frenetic' appearance subsequent to the extended prednisolone treatment.

Most compelling however, have been the results of

two additional wheel running studies in which rats received repeated treatment of dexamethasone, another
potent glucocorticoid (Beatty, Scouten, and Beatty,
1971~

Kendall, 1970) •

In both these experiments, wheel

running was markedly enhanced.
Which factor(s) accounts for this discrepancy
across reports remains unclear.
ities suggest themselves.
might be important.

At least two possibil-

First, a procedural variable

In both dexamethasone studies rats

received repeated, daily test sessions whereas in Experiment no. 1 wheel running was sampled only once, at
the end of chronic drug treatment.

It may be that drug

treatment interacts with previous history in the test
apparatus to determine test outcome.

A second plausi-

bility is that dexamethasone and prednisolone possess
different properties with respect to locomotor effects.
This later suggestion seems unlikely as most glucocorticoids share the same properties in a variety of
assays, and differ only with respect to potency (e.g.
Haynes and Murad, 1980).

Further, even replacement

doses of another glucocorticoid, corticosterone, known
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to act with generally lower potency and shorter duration
than either dexamethasone or prednisolone, has also been
shown to enhance wheel running (Leshner, 1981).

As

such, Experiment II was designed, in part, to re-examine
the effects of chronic prednisolone upon wheel running
in rats.

Here subjects were exposed to running wheel

test sessions on a daily basis.

It was reasoned that if

the procedural hypothesis were true, then a dose by

day~

interaction would emerge.
Two other factors were influential in execution of
Experiment II.

Experiment I demonstrated clear effects

of drug on water intake, body weight, and adrenal mass
in weanling male rats.

Experiment II sought extension

of these findings to a second population, adult females.
Additionally, clinical reports have suggested marked
changes in both affect and carbohydrate metabolism,
therefore, further characterization of these was sought
in measures of muricide and blood glucose.
Method
Subjects
Twenty-four adult, female Sprague-Dawley rats, bred
and raised in this laboratory's colony served as subjects.

The animals weighed approximately 262 ± 4.6gm (X

± S.E.) at the beginning of study.

All subjects were

housed, fed, and watered in individual stainless steel
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cages (32cm x 24cm x 20cm) (Unifab Corp., Kalamazoo, MI)
under conditions of constant temperature (23°
illumination.

c, ca) and

Subjects were offered Purina Laboratory

Chow (Ralston Purina Co., St. Louis, MO).

Previously

all animals had been extensively handled.
Apparatus
n

Water Intake Monitors
Water intake was measured by use of inverted 100-ml
polystyrene, graduated cylinders (Corning #25500,
Corning Glass Works Co., Corning, NY).

Fluid reservoirs

were plugged with number 6 stoppers and associated drink
spouts, and then affixed to cages.
Body Weights
Individual body weights were determined daily with
a top loading scale (Pelouze Model 1000, Pelouze Co.,
Evanston, IL).
Adrenal and Kidney Weights
Excised glands were weighed on a Mettler H54
Analytic Balance (Mettler Co., Switzerland).
Locomotion
Motor activity was measured for each subject on one
of three standard Wahmann Running Wheels(Wahmann Co.,
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Baltimore, MD).

Each wheel (35cm dia x llcm wide) was

equipped to electronically sense revolutions in both directions.

Running wheels were placed in separate, sound

attenuating chambers (6lcm x 6lcm x 6lcm) equipped with
masking noise (80 db), forced air ventilation, and illumination (7.5 volt, G.E.).
Muricide Assay
Twenty-four female CF-1 mice ranging in body weight
from 20-30 gm were used to measure

muricide~

one mouse

having been inserted into each rat's cage for 24 hours.
Blood Glucose
Blood samples, obtained via heart puncture using
18-gauge needles affixed to 1.0 cc syringes, were taken
while subjects were under deep ether anesthesia.

Plasma

was separated from whole blood (0.45 rnl samples, including 0.05 ml aliquot of Heparin Sodiumi Henry Schein,
Inc., Flushing, NY), by operation of a centrifuge
(Sorvall Type SS-1, Ivan

Sorvall~

Inc., Norwalk, CT).

Twenty microliter portions of these samples were added
to solutions of glucose-analysis freeze-dried enzyme
regent (Glucostat, Ortho Diagnostics, Raritan, NJ) •
Optical densities of these preparations were then determined by use of a spectrophotometer.
Procedure
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Body Weight, Wheel Running, and Water Intake
On each of 12 days, subjects were weighed and subsequently given intramuscular injections such that
groups were treated in a counterbalanced fashion across
time of day.

Thirty minutes post-injection, subjects

were exposed to daily 30-minute running wheel sessions
and returned to home cages for water intake monitoring.
Water intake was monitored by noting number of milliliters absent (net changes) from fluid reservoirs over
12 consecutive 24-hour periods.

At the end of each

24-hour period (while subjects were in locomotion test
sessions) , reservoirs were emptied and then re-filled
with fresh water.
Muricide
On Drug Day 12, one mouse was placed in each rat's
cage immediately following the running wheel session.
Exposure of each subject to a mouse continued for 24
hours after which time percent mouse mortality was
assessed.
Plasma Glucose Determination
When the muricide assay_was completed on study Day
13, subjects were placed under deep ether anesthesia.
Blood samples were obtained by heart puncture, combined
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with heparin sodium, and centrifuged for 20 minutes at
1500 rpm's.

Derived plasma was then frozen and analyzed

at a later date.

At analysis, samples (0.020 ml) were

combined with 3.0-ml aliquots of glucose analysis enzyme
solution.

Optical densities of these preparations were

assayed, in duplicate, via spectrophometer and then
converted to plasma glucose concentrations.
Adrenal and Kidney Weights
Following sacrifice of subjects, pairs of adrenals
and kidneys were excised and absolute weights obtained.
Relative organ weights were then computed.
Drug Preparation and Administration
Stock suspensions of prednisolone acetate (50
mg/ml) (Carter-Glogan, Glendale, AZ) were diluted with
physiolog- ical saline to concentrations of 8.0, 16.0,
and 32.0 mg/ml and administered at 1.0 ml/kg volumes by
intramuscular injection.

Dosage levels of 0.0, 8.0,

16.0, and 32.0 mg/kg were assigned to four groups of six
subjects each.

This dose range was selected by refer-

ence to the previous prednisolone study of Experiment
no. 1.

All injections occurred thirty minutes before

daily running wheel sessions.
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Statistical Analysis
Daily running wheel activity, water intake, and
body weight data were analyzed by repeated measures
analysis of variance (ANOVA)

(Hayes, 1963).

Absolute

and relative organ weights, Day 13 body weights, muricide results, and plasma glucose determinations were
analyzed by use of one-way ANOVA procedures (Hayes,
1963) •

Results of all measurements were reported graph~

ically as group means ± standard errors

(N=6/group) •

Results
Prednisolone Effects on Locomotion
The effects of dose of repeated prednisolone treatments upon daily wheel running activity across 12 days
is displayed in Figure 5.

The graph shows in general

that as dose and as number of drug treatments increased,
so too did number of revolutions performed.

Thus the

maximum number of revolutions performed by each group
were as follows: 0.0 mg/kg: 249 ± 36 (Day 6); 8.0 mg/kg:
386 ± 66 (Day 9); 16.0 mg/kg: 472 ± 65 (Day 10); and
32.0 mg/kg: 406 ± 66 (Day 9)

(X ± S.E. revolutions).

Statistical analysis by repeated measures two-way ANOVA
demonstrated a significant effect of number of administrations (f= 18.555, df= 11/264, p(0.001), a significant
dose X number of administrations interaction (f= 1.77,
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Figure 5. The Effects of 12 Daily IM Prednisolone Treatments Upon Number of Wheel-Running Revolutions
in Adult Female Rats.

On Each Day, Subjects

were Injected and 30-minutes Later were Exposed to Individual 30-minute Locomotion-Assay
Sessions.

Each Point Represents a Group Mean

±Standard Error (N=6/Group).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

38

-

N

..·'

at

D

~

'atE

at

E

CD

N

CD

It)

1-

z

LaJ

:i
t-

0

<t
a:

LLJ.

1LL

0 ..

N

Ot
~

I&J·

z

-

'E

UJ

-

Ot

. .J

<t

0
0.
It)

. en
><(
0

CD

U)

.,
0

0

o·

-

0

SNOI.Ln10I\3~

0
0
It)

.:10

.,
0

0

0
0

-·

~38WON
.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

·.

39

df= 33/264, p(0.008), but a main effect of drug dose,
per se, was only seen at the 8% level of significance
(f= 2.592, df= 3/23, p(0.081).
Prednisolone Effects on Water Intake
The average amounts of water consumed (milliliters)
for each dose group are plotted across days of treatment
in Figure 6, where marked differences in water intake
can be noted.

Repeated measures two-way ANOVA proced-

ures indicated that there existed significant effects
related to the number of treatments (f= 7.175, df=
11/264, p<0.001) and an interaction between number of
treatments and dose of drug (f= 2.149, df= 33/264,

p~

0.001), yet an unambiguous main effect due to dose alone
was lacking (f= 2.548, df= 3/23, p(0.085).

Inspection

of Figure 6 shows that while water intake by the saline
group remained rather high and stable (e.g Day 4: 33.3 ±
2.

Day 8: 51.0 ± 3.8

mls~

mls~

Day 12: 49.0 ± 4.2 mls),

that of the 8.0 mg/kg group dropped to and remained at
lower levels (e.g. Day 4: 33.3 ± 2.7
2.~ mls~

Day 12: 49.0 ± 4.2 mls).

mls~

Day 8: 35.3 ±

The intake of these

two groups is to be contrasted with the intake suppressions of the 16 mg/kg and 32 mg/kg groups which was
followed by gradual elevations up to and above the
control group's performance (e.g. 16 mg/kg: Day 4: 44.3
± 10.7

mls~

Day 8: 46.5 ± 6.7 mls1 Day 12: 62.5 ± 5.9
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Figure 6·. The Effects of 12 Daily IM Prednisolone Treatments Upon Number of Milliliters of Water Consumed per Day in Adult Female Rats.

Drug In-

jections Occurred Immediately Before each 24hour Observation Period.

Each Data Point Rep-

Resents a Group Mean ± Standard Error
(N=6/group).
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mls1 32.0 mg/kg: Day 4: 24.8 ± 2.0 mls1 Day 8: 43.0 ±
5.5 mls1 Day 12: 57.2 ± 10.4 mls).
Prednisolone Effects on Total Body Weights
Daily prednisolone acetate injections markedly decreased total body weights1 these results are portrayed
in Figure 7.

Figure 7 displays number of grams of body

weight change as a function of number of days of injection, for each of the four dosage groups.

On Drug Day

12, the 0.0, 8.0, 16.0, and 32.0 mg/kg groups weighed
266.7 ± 15.8, 207.0 ± 6.3, 206.3 ± 3.1, and 201.3 ± 8.6
gm, respectively.

A repeated measures two-way ANOVA

procedure revealed that a main effect of dose had been
observed (f= 4.996, df= 3/23,

p(0.010).

An effect of

number of drug treatments was significant (f= 180.585,
df= 33/264, p(O.OOl), as was the interaction of dose X
number of treatments (f= 19.795, df= 33/264, p(0.001).
An one-way ANOVA analysis of body weights across groups
on Drug Day 12 indicated that the differentially treated
groups' weights had diverged significantly (f= 10.25,
df7 3/23, p(0.001).

Taken together, the body weight

data show that as prednisolone dose increased, there
occurred a corresponding decrease in body weight.
Further, this measure of drug toxicity increased as the
number of drug treatments increased.

In addition, as
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Figure 7. The Effects of 12 Daily IM Prednisolone Administrations Upon Average Changes in Body Mass
for Adult Female Rats.

"Day 1" Entitles those

Body-Weight Changes Found 24 Hours after the
First Drug Administrations were Given.

Each

Data Point is a Group Mean ± Standard Error
(N=6/Group).

Weight Changes were Calculated

with Each Group Having Served as its Own
Control.
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·body weight loss progressed, so too did locomotion enhancements increase (see Figure 8).
Prednisolone Effects on Muricide
Muricide assays were conducted on Day 12 of drug
treatments and significant differences in these emerged
as a function of dose.

With an N of 6 per group, the

saline animals killed no mice, the 8.0 mg/kg group
killed one, the 16.0 mg/kg group killed four, and the
32.0 rng/kg group killed five.

One-way ANOVA analysis

revealed that these results were statistically significant (f= 6.296, df= 3/23, p(0.003).

Further analysis

with the Least Significant Differences Simultaneous
Testing procedure indicated that significant differences
existed between the saline group and each of the 16.0
and 32.0 rng/kg groups (ptO.Ol), and that significant
differences existed between the 8.0 mg/kg and the 16.0
mg/kg subjects (p(O.OS) and the 32.0 mg/kg group (p<
0.01).

These effects are displayed in Figure 9 (top

panel) where number of mice killed is plotted as a
fu~ction

of drug dose.

Prednisolone Effects on Blood Glucose
Twenty-four hours after·the last drug injection,
bloo~

samples were taken and subjects sacrificed.

Subsequent analysis of plasma glucose levels showed a
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Figure 8. The Correlation of Wheel-Running Values and
Body-Weights, for All Subjects Consider
Erunass, Plotted as a Function of "Day of
Treatment".

(N=24 Adult Female Rats).
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direct, linear relationship between drug dose and
glucose concentration These data are presented in Figure
9 (center panel).

The 8.0 mg/kg group's glucose level

was 205% of control, the 16.0 mg/kg group's was 249% of
control, and the 32.0 mg/kg group's glucose was 340% of
control, thus indicating all prednisolone-treated groups
as hyperglycemic, in that plasma glucose concentrations
twice normal are typically considered such.

One-way

ANOVA procedures demonstrated significant differences
between groups (f= 6.027, df= 3/23, p(0.004).

Further

analysis via the Least Significant Simultaneous Testing
procedure demonstrated the saline control group to be
significantly different from the 16.0 mg/kg (p(O.OS) and
32.0 mg/kg subjects (p(O.Ol), but not the 8.0 mg/kg
group (p<O.lO).

In addition, the 8.0 mg/kg group was

shown to be significantly different from the 32.0 mg/kg
(p(O.OS).

A comparison between the plotted glucose

values as a function of dose level (Figure 9, center
panel) and the plotted group body weights on the last
day (Figure 9, bottom panel) reveals that as body weight
de9lined, plasma glucose rose.
Prednisolone Effects on Adrenal and Kidney Weights
Analysis of absolute and relative weights of
excised organs showed that prednisolone produced a
selective, dose-related decay in adrenal weights as
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Figure 9• The Influence of Dose of 12 Daily Prednisolone
Treatments Upon Each of the Following Three
Dependent Variables:

(a) (Top Panel) Number

of Muricidal Killings During a 24-hour Exposure (N=6/Dose Group); (b) Plasma Glucose ConCentrations Determined on Day 12 of Study; (c)
Absolute Body Weights (in Grams) Taken on Day
12 of Study.

The 3 ·Panels are here Presented

Simultaneously to Highlight the Generally Parallel Nature of the Muricide and Glucose
Curves (Top Two) and to Juxtapose these with
the Inverse Nature of the Curve for Body
Weight (Bottom).
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qompared both to total body and to kidney weights.
These data are presented in Figure 10.

Animal weights

were significantly suppressed for all prednisolone
groups as compared to saline control (One-way ANOVA: f=
69.60, df= 3/23, p(0.001; L.S.D. procedure showing
saline group differed from each drug group at p<0.01).
As previously indicated, total body weights declined as
drug dose increased.

Yet analysis of relative adrenal

weights demonstrated adrenals to decay more quickly than
overall body mass.

Difference across groups, in rela-

tive weight of adrenal pairs, were significant (One-way
ANOVA: f= 20.48, df= 3/23, p(0.001).
Absolute weights of kidney pairs did not differ
significantly across treatment groups (One-way ANOVA: f=
0.38, df= 3/23, p(0.768).

There was, however, signif-

icant differences across groups as to relative kidney
weights (One-way ANOVA: f= 14.19, df= 3/23, p(0.001),
showing that overall body weight decayed while kidney
mass remained relatively unaffected.
Discussion
Experiment no. 2 clearly demonstrated that repeated
prednisolone treatment could markedly and chronically
elevate locomotor activity.

This discovery may have

critically depended upon the use of daily behavioral
test-apparatus exposures, since in Experiment no. 1 no
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Figure 10.

The Effects of Dose of 12 Daily Prednisolone
Treatments Upon Both Absolute and Relative ·
Adrenal and Kidney Weights.

Each Data Point

is a Group Mean± Standard Error (N=6/Group).
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significant locomotor effect of prednisolone was found
in a procedure where only a single apparatus exposure
was employed.

Other differences between the two exper-

iments - such as differences in subject characteristics
- precluded unambiguous conclusion, however.
Experiment no. 2 also confirmed and extended those
findings regarding prednisolone effects upon water
intake as well as body and adrenal weights, as these
were uncovered in Experiment no. 1.

Novel discoveries

included the marked impact of prednisolone upon both the
predatory attack measure and the blood glucose measure.
In, particular, it was speculated that the noted hyperglycemia could plausibly have been related in a causal
manner to changes in affective responses, body weight
decrements, and enhanced wheel running activity.

These

issues are discussed at greater length in the General
Discussion section.

Suffice it to say here that the

emergence, again, of the marked weight loss under prednisolone treatment produced further questions as to the
nature of the weight loss mechanism.
hy~otheses

One of the simpler

is that the weight loss accrues simply be-

cause of decreased food intakes.

One common reason as

to why food intakes drop in circumstances of drug toxicity is that a strong conditioned taste aversion has
developed wherein a drug has come to function as a UCS
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in a form of respondent learning process.

Experiment

no. 3 directly analyzed this plausibility.
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CHAPTER IV
EXPERIMENT III. CONDITIONED TASTE AVERSION IN ADULT FEMALE RATS WITH PREDNISOLONE AS UNCONDITIONED STIMULUS
AND SUCROSE AS CONDITIONED STIMLUS.
Introduction
Severe anorexia and associated weight loss constitute formidable problems for the cancer patient
(Costa, 1963; Dudrick and Copeland, 1974; Morrison,
1976; Theologides, 1972).

Such anorexia appears to be

multiply determined, resulting from both the direct and
indirect sequelea of the disease process itself, as well
as a direct consequence of chemotherapy and irradiation
treatments (Cairns and Altman, 1979; Frytak and Moertel,
1981; Harris, 1978; Morrison, 1976; Scogna and Smalley,
1979).

Recently, several authors have suggested that

acquired taste aversions may also pl·ay an important role
in cancer-related anorexia (Altmaier, Ross, and Moore,
1982; Chang, 1981; Redd and Andresen, 1981; Redd,
Andresen, and Minagawa, 1982; Swanson, Swensen,
Huizenga, and Nelson, 1976).

Anecdotal accounts from

oncologists (Kutz, Borysenko, Come, and Benson, 1980;
Whitehead, 1981) as well as systematic analyses of
chemotherapy recipients (Bernstein, 1978; Nesse, Carli,
Curtis, and Kleinman, 1980) support this view.

In gen-

eral, the mechanism by which such acquired shifts in
56
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food preference and intake occur has been ascribed to
the conditioned taste aversion (CTA), or gustatory
avoidance process (Bernstein, 19787 Bernstein, 19807
Kutz, Borysenko, Come and Benson, 1980).

In this,

acquisition of taste aversion is conceived to occur
according to respondent conditioning principles wherein
gustatory and/or olfactory stimuli (conditioned stimuli,
CS) are temporally related (paired) with illness-inducing aspects of the chemical and/or radiological agent(s)
(unconditioned stimuli, UCS).

Subsequently, the organ-

isms so exposed will avoid contact with such previously
neutral stimuli.

To the extent that many aspects of the

patient's diet are paired with cachexia-inducing aspects
of treatment agents, generalized anorexia may result.
This view has been corroborated by experiments using
laboratory animals in which CTA has been demonstrated
with radiation (Garcia, Kime1dorf, and Koelling, 19557
Smith, Hollander, and Spector, 1981) as well as with
certain anti-neoplastic drugs, including cyclophosphamide (Dragoin, Hughes, Devine, and Bentley, 19747 Elkins,
19747 Garcia, Kimeldorf, and Koelling, 1967), functioning as the

ucs.

The MOPP chemotherapy regimen, effectively employed
·in the treatment of Hodgkin's disease, has attained particular notoriety for its induction of severe gastrointestinal (GI) disturbances, as well as associated

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

58

'anticipatory' nausea and vomiting (e.g. Peterson and
Popkin, 19807 Stewart and Benjamin, 19797 Whitehead,
1981) •

As such, demonstration-type CTA studies have

been conducted with human chemotherapy recipients of
vincristine, procarbazine, and nitrogen mustard
(Bernstein, 1978) , three of the four members of the MOPP
combination.

Each of these agents has been shown to

induce marked gustatory avoidance (Bernstein, 1978).

No

CTA analyses, however, have been conducted in either
humans or laboratory animals to assess the fourth member
of the MOPP treatment.

This agent is prednisolone (or

alternately, prednisone), a potent synthetic glucocorticoid useful not only against Hodgkin's disease, but
also various lymphomas, leukemias, and certain solid
tumors (Haynes and Murad, 19807 Katzard and Caroll,
1978) •

A thorough-going analysis of all MOPP-induced GI

disturbances is called for since such GI disturbances
have (1) limited the dose and duration of therapy employed, and (2) critically jeopardized patient compliance (Freireich, 19797 Whitehead, 1981).
Several lines of evidence collectively suggest that
prednisolone might be effective in the instatement of
CTA.

Adrenalectomy (Balagura, Brophy, and Davenport,

19727 Balagura and Smith, 19707 Cullen, 1969) has been
demonstrated to markedly alter the acquisition and extinction of CTA where some other non-glucocorticoid
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agent (e.g. radiation, lithium chloride) was employed as
the UCS.

Second, endogenous corticosterone levels have

been found elevated during acquisition and extinction of
CTA where either cyclophosphamide or lithium chloride
functions as the UCS (Ader, 1976; Hennessy, Smotherman,
and Levine, 1976; Smotherman, Burt, Rimble, Strickrod
and BreMiller, 1981; Smotherman, Hennessy, and Levine,
1976).

Third, pretreatment with the anterior pituitary

peptide adrenocorticotrophic hormone (ACTH) (Hennessy,
Smotherman, and Levine, 1976; Hennessy, Smotherman, and
Levine, 1980; Rendler, Hennessy, Smotherman, and Levine,
1979; Levine, Smotherman, and Hennessy, 1977) and various fragments thereof (e.g. Ritger and Popping, 1976;
Smotherman and Levine, 1978), have been shown to modulate .the extinction of CTA.

Fourth, pretreatment of CTA

subjects with the synthetic glucocorticoid dexamethasone
has been found to change CTA acquisition and extinction
rates (Hennessy, Smotherman, and Levine, 1976, Hennessy,
Smotherman and Levine, 1980).

Finally, direct analysis

of corticosterone effects upon the feeding behavior of
rodents has demonstrated a hi-tonic dose- response function (Panksepp, 1975).

How glucocorticoids may function

as unconditioned stimuli in the CTA procedure has not
been evaluated, however.

The present study thus ex-

amined prednisolone's effect in this regard using rodent
subjects.

Water intake and body weights were also
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monitored in an effort to evaluate potential generalized
adipsia and systemic toxicity.
Method
Subjects
Twenty-four adult, female Sprague-Dawley rats (150
qm, ca), bred and raised in our colony, served as subjects.

The rats were housed individually under con-

ditions of constant temperature (23°
ation.

c, ca) and illumin-

Purina Laboratory Rodent Chow (#5002) (Ralston

Purina Co., St. Louis, MO)·was continuously available in
home cages.

All subjects were naive with respect to the

procedure, the conditioned stimulus, and the drug treatment employed.
Apparatus
Fluid Intake Monitors
Fluid intake was measured via modified 50-ml disposable syringes that functioned as fluid reservoirs
(Becton- Dickinson, Rutherford,

NJ~

model #Bect-5605).

The syringe barrels, with plungers removed, were plugged
with number 5 rubber stoppers and associated drink
spouts, and were then occluded at the needle end by
heating.

The reservoirs were subsequently filled with

water, inverted, and attached to individual, stainless
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steel cages (32cm X 24cm X 20 em; Unifab Corp.,
Kalamazoo, MI).
Total Body Weights
Individual body weights were determined daily with
a top loading scale (Pelouze model no. 1000, Pelouze
·Co., Evanston, IL).
Procedure
At study initiation, subjects were divided into
four groups of six rats each and randomly assigned to
one of four different dosage levels:
32.0 mg/kg prednisolone acetate.

0.0, 8.0, 16.0, or

The conditioned taste

aversion (CTA) procedure involved the repeated, differential pairing of a novel gustatory stimulus (CS)

(15%

sucrose : tap water, w/w) with immediately subsequent
prednisolone treatment (UCS) •

The general CTA procedure

has been extensively demonstrated and discussed by
others (e.g. Bernstein, 1978; Garcia, 1955, Levine,
Smotherman, and Hennessy, 1977; Rigter and Popping,
19?6).

Specifically, six sucrose CS presentations were

given with the last five serving as aversion tests.

The

final CS presentation was not followed by drug treatment.

CS presentations were given every third day, and

were six hours in duration.

At all other times, un-

adulterated tap water remained in the fluid reservoirs.
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.
.

All fluid intake was assessed by noting number of
milliliters absent from graduate reservoirs attached to
each hpme cage.

In each CTA test, aversion was assessed

by comparing sucrose intake differences between drugtreated groups and control subjects.

Twenty-four hour

water intake measurements were conducted the day following each sucrose presentation, with six determinations
conducted for each subject.

The purpose of monitoring

intermittent prednisolone effects on water, per se, was
to evaluate whether alterations in sucrose intake were
due to generalized adipsia.

A total of 22 daily, fluid

intake sessions were conducted for each subject.

Body

weights were taken daily at approximately 12:00 noon.
Drug Preparation and Administration
Stock suspensions of prednisolone acetate (50
mg/ml) (Carter-Glogan, Glendale, AZ) were diluted with
physiological saline to concentrations of 8.0, 16.0,
32.0 mg/ml and administered at a volume of 1.0 ml/kg by
intramuscular injection.

Four groups of six animals

each were administered the prednisolone at one of the
following four dosage levels: 0.0, 8.0, 16.0, or 32.0
mg/kg.

Injections occurred immediately after termina-

tion of each of the first five sucrose exposures (CS
trials).
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Statistical Analysis
Water intake, body weight, and sucrose consumption
were each analyzed by use of repeated measures two-way
analysis of variance (ANOVA) procedures.

Means and

standard errors were calculated and plotted for each
group, for each of the three dependent measures
employed.
Results
Figure 11 displays the effects of the intermittent
(every third day) prednisolone treatment upon water intake during the 24 hour periods that followed each injection.

In this 'Pre' refers to the intake that occur-

red the day 48 hours previous to the first aversion
trial.

Observation Day 18 refers to the intake that

occurred the day following the last aversion test, which
was four days following the last drug injection.

Evi-

dent are definite differences in water intake between
control and drug groups early in the regiment (Observation Days 3, 6, and 9).

However, by Observation Day 12,

the rate of water intake had partially recovered, and
the trend for recovery increased on Observation Days 15
and 18.

Thus, on Observation Day 9 the following abso-

lute intake data (mls} were gathered:

Saline: 29.8 ±

1.9 mls: 8.0 mg/kg: 17.3 ± 1.7 mls: 16.0 mg/kg: 23.3 ±
1.1 mls: and 32.0 mg/kg: 24.7 ± 2.7 mls.

Yet on
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Figure 11.

The Effects of Every-Third Day Prednisolone
Treatments Upon Number of Milliliters of
Water Intake During the 24-hour Periods
Following Each Injection.

'Pre' Refers to

that Intake Which Occurred Two Days Before
the First Drug Treatment.

Observation Day

#7 Refers to that Intake Which Occurred in
the Day Following the Last Aversion Test,
but Four Days Following the Last Drug
Injection.

Each Point Represents a Group

Mean (N=6/Group).
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Observation Day 18 a relatively complete recovery of
intake had occurred for all drug groups vis ~ vis
control subjects as the following data (mls) indicates:
Saline: 29.9
mg/kg: 28.8

± 1.5 mls~ 8.0 mg/kg: 29.0 ± 1.7 mls~ 16.0
± 2.3 mls~ and 32.0 mg/kg: 29.0 ± 1.7 mls.

A repeated measures two-way ANOVA procedure demonstrated
that there had occurred significant differences in water
intake as a function of dose (f=

3.026~

df= 3/23: p<

0.054), but not a number of observations (f=
15/120~

0.515~

df=

p<0.764) nor of a dose-by-observations inter-

action (f=

1.058~

df=

15/120~

p(0.405).

Presented in Figure 12 are the effects of repeated
sucrose (CS) pairings upon differences in sucrose intake, in which those groups that received drug (8.0,
16.0, or 32.0 mg/kg) are compared to the group that
received saline only (0.0 mg/kg).

The ,dotted line

refers to saline control performance against which
consumptions of the drug groups were compared.

The

degree of divergence in sucrose intake between groups
receiving prednisolone and saline control subjects
increased as the number of aversion tests increased (see
Figure 12).

Thus, by Aversion Test no. 5, the following

absolute sucrose consumptions had been obtained for the
following groups:

Saline: 27.3 ± 2.4

mls~

8.0 mg/kg:

19.2 ± 1.0 mls; 16.0 mg/kg: 15.7 ± 1.7 mls; and 32.0
mg/kg: 13.8 ± 3.1 mls.

Relative to the saline control
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Figure 12.

The Effects of Repeated Sucrose (CS) - Prednisolone (UCS) Pairings Upon Differences in
Sucrose Intake, Contrasting Those Groups
Which Received Drug to that Which Received
Saline.

The Dotted Line Refers to Saline

Control Performance, with Respect to which
the Consumptions of the Drugged Groups were
Compared.

Each Point Represents a Group

Mean (N=6/Group).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

68

.
.

en
.....
U)

I

•
•••.
•
••
I

'

w

.

I-

I
I
I

z

0

en
0::

w

~

oo 0
.x.x.¥

,,,

C\1

LL
0

gaOO

E E E

.....

0::

m«>"'
-~

w

CD
::;E

••
•••
•
••

z=>

I

0

+

1()

+

0

l()
I

0

I

l()

-

I

0

(\J

LO

C\1
I

( S~3J.Illll1LAJ)
3>1Vl.NI
3SO~~ns

Nl

3~N3CJ 3.:J.:JIO

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

69.

group performance, such values translate to the following difference scores:
mg/kg: -11.3

±

8.0 mg/kg: -7.8 + 1.0 mls; 16.0

1.7 mls; and 32.0 mg/kg: -13.2 + 2.5 mls •

. A repeated measures two-way ANOVA procedure analyzing
difference scores revealed that there had occurred significant differences in sucrose intake as a function of
drug dose (f= 6.547; df= 3/23; p(0.003), of number of
aversion trials (f= 7.195; df= 4/96; p(O.OOl), but not
of a dose-by-trials interaction (f= 1.118; df= 12/96; p(
0.358).

Comparisons of Figures 1 and 2 revealed no cor-

respondence in the rank orderings of groups with regard .
to respective fluid intakes.
Illustrated in Figure 13 are the effects of intermittent prednisolone treatment (every third day) upon
average body weights (grams) for each dosage group.
Figure 13 shows that as the number of drug treatments
increased, so too did the difference in weight between
the control and drug groups.

This was due to steadily

accruing weights of saline-treated subjects and continued decrements in body weights of prednisolone-treated
an~mals.

Thus, by Sucrose Presentation no. 6 the fol-

lowing body weight (gm) data had been recorded:

Saline:

211.8 + 6.9 gm; 8.0 mg/kg: 124.8 + 3.6 gm; 16.0 mg/kg:
126.0 + 5.2 gm; and 32.0 mg/kg: 119.2

± 5.3

gm.

A

repeated measures two-way ANOVA test indicated that
there were highly significant effects of dose (f=
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Figure 13.

The Effects of Every-Third-Day Prednisolone
Treatments Upon Average Body Weights
(Grams).

Data Points Represent Group Means

and Standard Errors (N=6/Group) Assessed on
Days of Drug Injection.
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32.081J df= 3/23J p(0.001), of number of drug treatments
(f= 10.593; df= 5/120J p<0.001), and of a dose-by-treatments interaction (f= 52.638J df= 15/100J p(0.001).
Discussion
As displayed in Figure 11, prednisolone acetate
treatments given every third day yielded dose-related
decrements in water intake.

These decrements were not

related to either number of observations or to a doseby-observations interaction, however.

A clear recovery

of intake for drug-treated groups occurred by study termination.

In general, these effects (i.e. early pred-

nisolone- induced hypodipsia followed in latter sessions
by at least partial recovery) were similar to those
previously noted (Experiments no. 1 and 2).
One potential mechanism mediating the early hypodipsia (note in Experiments no. 1, 2, and 3) may relate
to known glucocorticoid effects upon electrolyte balance
(Haynes and Murad, 1980).

Glucocorticoids induce marked

sodium retention by both renal and gastrointestinal proce~ses

(Haynes and Murad, 1980J Richards, 1969).

As

sodium is retained, water passively follows and extracellular hypervolemia ensues (Haynes and Murad, 1980).
Anti-diuretic hormone (ADH) synthesis and release may
also be enhanced, producing further renal reabsorption
of water (Guyton, 1979).

Thus, potential prednisolone-
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induced increments of extra-cellular volumes may have
yielded protracted suppression of water intake by altering volumetric thirst mechanisms.

These mechanisms have

been analyzed (Fitzsimmons, 1961; Gilbert and Glaser,
1961; Stricker, 1966; Stricker, 1969).

(See General

Discussion for further analysis of these issues.)
Water intake of all three drug-treated groups returned to pre-drug control levels by experiment's end.
This result is illustrated in Figure 11.

Although the

causal mechanism(s) of this effect remains unclear, four
potential mediating processes offer themselves.

First,

volume receptor activity, altered by enhanced extracellular volumes, might have been adapted and thus produced
a decline in both ADH release and the typical renal
sequelae to ADH release (Guyton, 1979) •

Second, dis-

tributions of water across intra- and extracellular
compartments may have altered via changed permeabilities
of membranes to water (Mills, 1965) and also a result of
enhanced free water clearance (Dingman, 1961) •

Third,

as extensive binding of glucocorticoids upon central
ne;vous system (CNS) tissues has been demonstrated
(Feldman, 1973; McEwen, 1973), it is plausible that both
initial intake decrements and subsequent restitution of
intakes occurred directly via CNS mechanism alterations.
Finally, as drug was withheld after the final aversion
trial (and thus before the last water intake on
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Observation Day 18) relative drug absence might have
been critical.

Arguing against this last alternative is

the fact that by Observation Day 15, some intake
reinstatement was already in evidence for each of the
three drug groups.
Repeated, intermittent pairings of a gustatory
stimulus and subsequent prednisolone treatment yielded a
gradually accruing avoidance of this stimulus (sucrose
solution) (see Figure 12).

There occurred little

difference in the degree of aversion displayed across
prednisolone dose groups although all differed significantly from saline-control subjects.

That water

intake data revealed reinstatement of control-level
drinking in all drug-treated groups by experiment's end
strongly suggests that decrements in sucrose intake were
not the result of a generalized adipsia (see Figure 12) •
These results show one member of the MOPP combination as capable of producing CTA in an animal assay.
As mentioned, procarbazine, vincristine, and nitrogen
mustard have exerted CTA effects in an experiment with
ch;ldhood cancer patients (Bernstein, 1978) •

It remains

unclear, however, whether and if so to what extent,
various drug interactions occur among MOPP agents in the
production of CTA.

Also obscure is the efficacy rank-

ordering of anti-emetics potentially useful against
MOPP-induced CTA (Kutz, Borysenko, Corne, and Benson,
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1980i Whitehead, 1981).

Further research should eluc-

idate these issues.
Using non-glucocorticoid agents as the

ucs,

various

manipulations of the pituitary-adrenal axis have been
shown to exert modulatory influences upon the acquisition and extinction of CTA.

These manipulations have

included adrenalectomy (Balagura, Brophy, and Davenport,
1972i Balagura and Smith, 1970i Cullen, 1969), dexamethasone treatments (Hennessey, Smotherman, and Lavine,
1976i Hennessey, Smotherman, and Levine, 1980), and
injections of ACTH or various fragments thereof
(Hennessy, Smotherman, and Levine, 1976i Hennessy,
Smotherman, and Lavine, 1980; Kendler, Hennessy,
Smotherman, and Levine, 1979; Levine, Smotherman, and
Hennessy, 1977i Rigter and Popping, 1976i Smotherman and
Lev~ne,

1978).

In addition, concurrent training of CTA

with serial corticosterone assays has revealed enhanced
levels of corticosterone during CTA acquisition and
performance (Ader, 1976i Hennessy, Smotherman, and
Levine, 1976i Smotherman, Burt, Kimble, Strickrod, and
BreMiller, 198li Smotherman and Levine, 1978).

The

present results demonstrate that a synthetic glucocorticoid, prednisolone, can function as the UCS in the CTA
paradigm.

Thus, the present results add further cred-

ence to the notion that the pituitary-adrenal axis may
be involved in the acquisition and performance of
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conditioned taste aversion.

It remains to be determined

whether prednisolone-induced CTA is the result of a
direct action on CNS tissues, an indirect action via
altered ACTH levels, or some other, as yet unidentified
mechanism.
Six potential mechanisms suggest themselves as at
least contributory to the marked weight loss found in
Experiment no. 3.

These are:

(a) modified protein

metabolism (Baxter and Forsham, 19721 Leob, 1976)1 (b)
drug-induce abatement of growth (Blodgett, Burgin,
Iezzoni, Gribetz, and Talbot, 19561 Falliers, Tan,
Szentivany, Jorgensen, and Bukantz, 19631 Liddle and
Melman, 19741 Loeb, 1976)1 (c) altered lipid metabolism
(Guyton, 1979)1 (d) enhanced excrement1 (e) increased
motor activity and associated facilitation of basal
metabolic rate (Leshner, 1971)1 and (f) decrements in
food and water intake (Praksepp, 1975).

The present

findings of prednisolone-induced CTA and hypodipsia are
relevant to the last alternative, yet the considerable
aformentioned data suggest that glucocorticoid effects
on.protein metabolism, growth abatement, and motor
activity are probably also operative.
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CHAPTER V
EXPERIMENT IV: DOSE-RESPONSE EFFECTS OF ACUTE
PREDNISOLONE (0,2,4,8, and 16 mg/kg) UPON VI-15"
MAINTAINED OPERANT BEHAVIOR FOR FOOD REINFORCEMENT
Introduction
The first three experiments clearly demonstrated
that repeated prednisolone treatments can produce a wide
range of behavioral effects.

Such results are in keep-

ing with clinical reports that high dose, repeated
glucocorticoid treatments do predispose recipients to
various psychiatric sequelae.

The first three experi-

ments employed relatively gross, biologically important
behavioral and physiological endpoints.
of the assays were impacted upon.

Virtually all

Direct indications of

prednisolone's behavioral activity came from measures of
(a) water intake, (b) wheel running, (c) analgesia, (d)
muricide, and (e) the grasping response, and (f) conditioned taste aversion.

Indirect, yet highly suggestive,

further evidence that prednisolone possesses far-ranging
benavioral effects came from such physiological indicators as changes in (a) body weights,

(b) selected

organ weights (i.e., adrenals versus gonads and kidneys), as well as (c) plasma glucose levels.

Collec-

tively, these data suggest that various forms of operant
behavior should also be profoundly altered.

This is so

77
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since from the above-described data the following conclusions can be drawn regarding prednisolone's effects:
(a) that a range of primordial functions are altered,
(b) that these included (1) locomotor functioning (e.g.,
wheel-running), (2) capacity for manual functioning
(e.g., the grasping response), (3) at least some aspects
of the sensorium (e.g., gustation and nocioception), (4)
the tendency to aggress toward and kill another organism
and (5) consumption of an appetitive reinforcer (e.g.,
water). In addition, the profound and dose-related changes in body weights and blood glucose levels, as well as
the appearance of conditioned taste aversion, strongly
suggest that food intakes may also be altered.
These conclusions directly suggest that both positively and negatively reinforced operant behavior is
likely to be changed under chronic glucocorticoid treatment.

To date, however, behavior analysts have little

examined the impact of the corticosteroids upon operant
behavior, save a few early reports correlating unsignaled avoidance and pituitary-adrenal activity (e.g.,
Si~an,

Mason, Brady and Thach, 19621 Wertheim, Conner

and Levine, 1967).

Therefore, the ensuing ten experi-

ments were conducted to assess the following six general
issues.
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(1) Are there effects of acute prednisolone treatments upon steady-state operant performances, even at
high doses?
(2) Does the

~

of maintaining schedule of rein-

forcement influence whether or not, and to what degree,
prednisolone impacts upon a stable operant performance?
(3) Do these potential, acute effects depend upon
the pre-treatment interval?
(4) Are there effects of chronic prednisolone
treatments which impact upon steady-state operant
performances?
(5) Are these plausible operant behavioral effects
of chronic prednisolone the result of straight-forward,
accruing toxicity, or an increasing sensitization to the
drug?
(6 ) Finally, will a previous history with prednisolone alter the organism's ability to further acquire
operant behavior?
Estimates are that approximately 40% of persons receiving high-dose, chronic glucocorticoid treatments
ev~ntually

exhibit various forms of a marked psychiatric

disorder.

Such psychiatric disturbances typically in-

volve either a frank psychotic reaction or a severe
depression.

Over the last forty years a vast amount of

evidence has accrued that operant processes are central
to a good deal of complex human performance, whether
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that behavior is 'normal' or compromised in some fashion
(e.g. Skinner, 1953: Honig, 1966: Honig and Staddon,
1977).

In particular, studies have shown that both

psychotic and depressive syndromes can be considerably
impacted upon by the manipulation of the environmental
contingencies of reinforcement- (e.g., Seligman, 1975).
Thus, the issue of whether the abnormal behaviors which
constitute a psychiatric disorder are primarily of
operant origin may be of secondary interest when
deciding whether operant processes are relevant to the
understanding and control of psychiatric sequelae.
Operant processes can (a) interact with disease processes to exascerbate the disorder: (b) directly produce
behavioral performances which are highly maladaptive,
'psychiatric' repertoires: (c) interact with the disease
process in a pallitative fashion: (d) serve to create
topographies which in many respects are strikingly similar to the disease-produced compromised performance:
and (e) be operative concurrently with those delimited
aspects of the repertoire which are compromised in some
circumspect fashion by the disease process (e.g., see
Davidson and Davidson, 1980).

In view of the above,

controlled operant baselines were judged to be useful in
documenting the potential range of impairment that may
occur under prednisolone treatment.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

81

The last 30 years has seen the rise of an important
inter-disciplinary field termed "behavioral pharmacology."

This field is actually multi-disciplinary, incor-

porating methods and assumptions from both behavior
analysis, from pharmacology, from chemistry and from
physiology among others.

During this period, numerous

important works have emerged exemplifying the broad
range of applications which operant methodologies can
have in the analysis of drug effects (e.g., see Seiden
and Dykstra,
and Sanger,

Thompson and Boren,

1977~
1978~

1977~

Anisman and Bignami, 1978).

Blackman
Such

works have outlined and illustrated how various aspects
of operant conditioning can be used to establish sensitive baselines upon which to assay a chemical's
behavioral effects.

Studies have shown that both posi-

tively reinforcing schedules such as variable-interval
(VI), fixed-ratio (FR), differential reinforcement of
low rate (DRL), and negatively reinforcing schedules
such as free- operant avoidance (i.e., Sidman avoidance)
are highly responsive to a range of drug influences.
Under VI schedules of positive reinforcement, behavior is maintained by the intermittent delivery of
response consequences, wherein there is an average
amount of time which passes after which the next response yields reinforcement.

This average is calculated

across the entire range of intervals which are employed.
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The behavioral pattern which results in the final
steady-state is one of relatively high, even rates with
few or no breaks in the performance.

This schedule en-

dangers behavior which is relatively resistant to extinction (Seiden and Dykstra, 1977) and is known to be
rather sensitive to many drug influences, as several
psychopharmacological studies have demonstrated.
Schoenfeld and Uretsky (1972), for instance, employed a
VI-90 sec. schedule of water presentation and demonstrated that rats treated with 6-hydroxydopamine gradually displayed a permanent four-fold enhancement in
VI-maintained response rates.

In another example, Green

and Harvey (1974) employed a VI-60 sec schedule of water
presentation to analyze the role which 5-hydroxytryptophan (i.e., 5-HTP) plays in the elaboration of amphetamine's behavioral effects.

Various central nervous

system (CNS) lesions were made in rats and varying doses
of amphetamine challenge were then given.

In general,

dramatic operant response rate increases were discovered
for only those rats whose lesions had strongly depleted
5-~T.

In addition, the following general classes of

drugs have been analyzed:
1958b~

psychomotor stimulants (Dews,

Kelleher, Fry, Deegan, and Cook,

Witoslawski, and Campbell,

1967~

1961~

Hanson,

Macphail and Gollub,

1975), antipsychotics (Waller, 1961; Waller and Waller,
1962; Hanson, Witoslawki, and Campbell, 1967),
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antianxiety agents (Kelleher, Fry, Deegan, and Cook,
1961i Wedeking, 1974), narcotic analgesics and narcotic·
antagonists (e.g., Thompson, Trombley, Luke, and Lott,
1970i Holtzman and Villarreal, 1973), hallucinogens
(e.g., Jarrard, 1963i Appel, 1971), tetrahydrocannabino1s (e.g., Grisham and Ferraro, 1972i Kosersky,
McMillan, and Harris, 1974i Dykstra, McMillan, and
Harris,

1975), cholinergic blockers (e.g. Hanson,

Witoslawski, and Campbell, 1967i Willis and Windland,
1968i Hines, Miller, and Lee, 1969, 1970), and
cholinergic agonists (e.g., Morrison, 1967).

Such

efforts have routinely found VI schedules to yield
sensitive, stable baselines upon which to assess the
influence of relatively low- dose chemical agents.

A

variable interval schedule was thus judged as potentially useful in further assessment of those behavioral
effects of prednisolone which were discovered in Experiments 1, 2, and 3.
Method
Subjects
Three female, adult Sprague-Dawley rats, bred and
raised in the laboratory's colony, served as subjects.
Subjects were individually housed, under conditions of
constant temperature (23° C) and a 12-hour day/night
cycle.

Subjects were allowed free-feeding until total
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body weights stabilized, and then were progressively
food- deprived to 80% of their free-feeding weights.
After establishing 80% weights, subjects were given
total daily rations (ca. 13 gm) to just maintain this
stable weight.

Subjects were similar in all other

respects to those described in Experiments no. 1 and 2.
Apparatus
All daily behavioral training and testing sessions
were conducted in

standar~

operant conditioning chambers

(24cm X 19cm X 28cm), equipped with grid floors, house
lights, food pellet (45 mg) dispensers, LeHigh Valley
water dispensers, and rodent response levers (32 gm
force requirement for micro-switch closure) •

Each

operant conditioning chamber was housed within constructed "isolation shells" equipped with sound and
lighting insulation, forced-air ventilation, masking
white-noise and viewing windows.

Interactive control of

the behavioral test sessions as well as the recording of
all behavioral responses was accomplished via the use of
st~ndard

electromechanical equipment located on the

other side of a large metal partition.
Procedure
Each subject was trained by the method of successive approximations (shaping) to lever press for re-
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inforcement

delive~y.

Thereafter, behavioral

requirements were gradually changed until the terminal
contingencies were in effect (VI-15" in this study) •
Behavioral stability was defined as response rate
variation of less than 10% from the mean of a three-day
period, and no trend shown in the rate across days.
Once behavioral stability was achieved for individual
subjects, intramuscular isotonic saline injections were
begun.

Control injections were continued until

stability was again achieved.

At this time, drug

injections were initiated (see Experiments no. 1--3 for
details as to drug preparation).

All drug treatments

occurred 30 minutes before daily test sessions.

In this

study, as well as in all other experiments in which
"acute" drug effects were investigated, single
administrations of prednisolone only followed a
three-day saline control period, during which stability
was demonstrated.

Subsequently, another set of daily

control sessions was conducted until stability was again
achieved.
cy~le

A new dose of the drug was then given and the

was then again repeated.

All data were plotted

and analyzed as percent of saline-control baselines, as
calculated for each subject.

Each subject was then con-

sidered to serve as its own control.
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Results
Figure 14 displays the results of Experiment no. 4.
Plotted here is the percent of baseline operant responding maintained by VI-15" food reinforcement, as a function of prednisolone dose (2,4,8 and 16 mg/kg).

Data

for each of the three subjects are presented individually (Rats no. 340, 171, and 164).

Effects for each

dose, in each subject, were examined twice, and thus the
averaged data are indicated and surrounded by the high
and low value at each dose.

For each of the three

subjects, no influence of acute prednisolone treatment
was evident.
Discussion
Experiment no. 4 determined that intramuscular administration of prednisolone (2,4,8, and 16 mg/kg),
delivered 30 minutes before behavioral testing, was
without observable effect when measured upon a VI-15"
food-maintained operant response.

Given the tremendous

array of behavioral and physiological effects documented
in'Experiments no. 1, 2 and 3 this result was of considerable surprise.

These previous experiments had

indicated that body weight loss was marked and precipitous, that blood glucose was markedly elevated, that
activity was particularly enhanced, that clear hypodipsia was evident, and that the endocrinological system
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Figure 14.

The Influence of Acute Prednisolone Treatments (2,4,8 and 16 mg/kg, IM) Upon VI-15
Sec. Operant Lever Pressing for 45 mg Noyes
Food Pellets, in Adult Rats.

Data are Plot-

ted Individually for Each of 3 Rats, as Percent of Saline-Control Baseline as a Function of Prednisolone Dose.

Each Subject

Received All Doses Twice, with Both the
High and Low Values Plotted Around Each
Mean.
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was significantly impacted upon.

All of these document-

ed effects suggested that reinforced operant responding
should have been markedly altered by high-dose prednisolone treatment.

There were several plausible, alterna-

tive explanations as to why this assay was without effect.

These were:

(a) the wrong positive reinforcer

had been selected (e.g., water should have been tried
instead)~

(b) VI schedules are relatively insensitive to

glucocorticoid effects (i.e., another reinforcement
schedule [e.g., FR] might have been more

sensitive)~

(c)

the pre-session treatment period was inappropriate
(i.e., pre-treatment times should have been

longer)~

(d)

appetitive reinforcers were inappropriate for display of
prednisolone behavioral effect (i.e., aversively maintained responding is more sensitive to glucocorticoid
influence).

Thus, an additional series of operant ex-

periments were performed to resolve these ambiguities.
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CHAPTER VI
EXPERIMENT V: DOSE-RESPONSE EFFECTS OF ACUTE
PREDNISOLONE
(0,2,4,8 and 16 mg/kg) UPON VI-15"
MAINTAINED OPERANT BEHAVIOR FOR WATER REINFORCEMENT
Introduction
Experiment no. 4 demonstrated a lack of acute
prednisolone treatment effect upon VI-15" food-maintained lever pressing.

Several potential variables might

have plausibly accounted for this rather unanticipated
effect.

Experiment no. 5 was designed to explore the

hypothesis that the lack of acute. prednisolone effect
had been a function of the type of reinforcer employed.
Perhaps, this notion goes, water reinforcement might
have provided an operant baseline a good deal more
sensitive to prednisolone effects than food reinforcement did.

Elimination of this plausibility is required

before it can be concluded that prednisolone is without
observable effect on operant behavior.

Therefore,

Experiment no. 5 was performed to assess,the influence
of"several acute prednisolone doses (0,2,4,8 and 16
mg/kg) upon water-reinforced VI-15 11 operant responding.

go
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Method
Subjects
Four female, adult Sprague-Dawley rats (Subjects
no. 29'1, 292, 293, and 294) were employed as subjects.
The subjects were given ad libitum access to rat chow in
the home cages.

The deprivation condition consisted of

no water in the home cage until after the daily 30-minute behavioral test session was completed.
10 ml of water were given.

At that time

In addition, subjects could

earn numerous 0.05 ml draughts of water during each
day's test session.
Apparatus
The apparatus employed in Experiment no. 5 was
identical to that which was used in Experiment no. 4.
Procedure
The positive reinforcer employed was 0.05 ml
draughts of water presented via LeHigh Valley water
di~pensers.

In all other respects, the procedure for_

Experiment no. 5 was identical to that of Experiment no.
4--except that each subject received each of the test
doses only once rather than twice as had been the case
in Experiment no. 4.
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Results
Figure 15 presents the results of Experiment no. 4.
Here, percent of baseline operant responding maintained
by VI-15" water reinforcement is plotted as function of
prednisolone dose.

Data for each subject (no. 291, 292,

293, and 294) are plotted individually.

When taken in

aggregate, the data suggest no clear effect as a function of increasing drug dose.

The behavior of Subjects

no. 291 and 292 appeared rather stable and unchanging as
dose increased whereas Subjects no. 293 and 294 appeared
more variable.

However, from none of the four subjects'

data can it be concluded that prednisolone yielded
behavioral impact on the operant response, across the
entire dose range examined.
Discussion
Experiment no. 5 determined that intramuscular
administration of prednisolone (2,4,8, and 16 mg/kg,
IM), delivered 30 minutes before behavioral testing, was
without observable effect when assessed upon a VI-15"
water-maintained operant response.

These results thus

corroborate those found in Experiment no. 4 in which
_ food reinforcement was employed.

It is thus·concluded

that acute prednisolone treatment is without observable
effect on variable-interval positively· reinforced
operant behavior in adult rats, regardless of the type

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

93

Figure 15.

The Influence of Acute Prednisolone Treatments (2,4,8 ;.ind 16 mg/kg, IM) _upon VI-15
Sec. Operant Lever Pressing for 0.05 ml
Draughts (ca.) of Water, in Adult Rats.
Data are Plotted for Each of 4 Rats, as
Percent of Saline-Contro'l Baseline as a
Function of Prednisolone Dose.

Each Sub-

ject Received all Doses Once.

·~
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of appetitive reinforcer used.

Experiment no. 5 thus

eliminates the "type of appetitive reinforcer" hypothesis which might have accounted for the lack of an
operant behavioral effect of prednisolone.

.

\
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CHAPTER VII
EXPERIMENT VI: TIME-COURSE OF ACUTE PREDNISOLONE
TREATMENT EFFECTS, WITH PRE-SESSION INJECTION TIMES
OF 0.5, 2.0, 4.0 and 8.0 HOURS, USING VI-15" WATERREINFORCED LEVER PRESSING AS THE ASSAY RESPONSE
Introduction
Experiment nos. 4 and 5 established that operant
responding maintained by VI-15"· positive reinforcement
was not observably affected by a range of prednisolone
acute dose treatments, regardless of whether the reinforcers were 45 mg food pellets or 0.05 ml water
draughts.

Given that those two experiments were to

employ acute dose procedures, a pre-session treatment
interval had been selected and adhered to -- that being
0.5 hours.

The 0.5 hr pre- treatment interval is, in

some senses, an arbitrary selection.

This had been

adopted largely because it had been used with considerable benefit in the previous analysis of numerous other
drugs.

It was plausible, however, that the 0.5 hr pre-

treatment interval was too short a period to allow the
behavioral test session to "capture" prednisolone-induced alterations in operant behavior which were, in
fact, occurring.

Steroids, when administered in suspen-

sion via intramuscular injection, are known to possess
both relatively slow onsets of action as well as relatively long durations of action.

For these reasons, it

96.
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was judged potentially fruitful to analyze
prednisolone's behavioral impact upon VI-maintained
responding, as a func·tion of time since intramuscular
drug administration.

A time-course of the drug's action

might conceivably emerge from this type of experimental
manipulation.

If such was the result, this would

provide an explanation for lack of behavioral effect in
Experiment nos. 4 and 5, as well as a technical fact to
exploit in further prednisolone - operant behavior
studies.
Method
Subjects
Subjects were three female, adult Sprague-Dawley
rats (Subject nos. 291, 292 and 294).

The subjects were

identical to those employed in Experiment no. 5, including as regards deprivation and reinforcement conditions.
Apparatus
The apparatus was identical to that employed in Experiment nos. 4 and 5.
Procedure
The procedure.was identical to that employed in Experiment no. 5, except for the following details.
First, the dose of drug was not varied.

A standard 16.0
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mg/kg IM prednisolone challenge was decided upon, with
which to explore the time-course issue.

The 16.0 mg/kg

dose was judged to be sufficiently high since Experiment
nos. 1, 2 and 3 had all indicated conclusively that this
dose level was markedly behaviorally active in numerous
non-operant assays, as well as in various physiological
measures.

Second, with the pre-set, standard challenge

dose the following "time-since- injection-intervals"
were explored: 0.5, 2.0, 4.0 and 8.0 hours.

In this

procedure, the subjects were injected and then placed
back into their home cages until the time for test
session arrived.

Otherwise, VI-15" test sessions were

conducted in a manner totally similar to those sessions
conducted in Experiment no. 5.
Results
Figure 16 displays the influence of acute, 16 mg/kg
IM prednisolone treatments upon VI-15" lever pressing
for 0.05 ml draughts of water reinforcement in adult
female rats.
ba~eline,

hours.

Data are plotted as percent saline-control

as a function of time since injection in

In this study, each rat served as its own con-

trol, and for each rat each pre-session interval was
examined only once.

As can be seen in Figure 16 no

systematic effect of varying pre-session injection time
could be discerned.

Though variability appeared
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somewhat marked across subjects, no general conclusion
could be drawn from the plotted data as to any systematic change.
Discussion
Experiment no. 6 indicated that varying the presession treatment time from 0.5 to 8.0 hours was largely
without effect.

This experiment thus generally elimin-

ated the "pre-treatment time" hypothesis as a substantial explanation for the anomalous lack of prednisolone
impact upon operant behavior as documented in Experiment
nos. 4 and 5.
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Figure 16.

Influence of Acute, 16 mg/kg IM Prednisolone
Treatments Upon VI-15 Sec. Lever Pressing
for 0.05 ml Draughts of Water Reinforcement
in Adult Rats.

Data are Plotted as Percent

of Baseline, as a Function of Time Since Injection in Hours.

In this Study, Each Rat

Served as its Own Control, and for Each Rat,
Each Pre-Session Interval was Employed Only
pnce.
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CHAPTER VIII
EXPERIMENT VII: INFLUENCE OF DAILY, REPEATED 16.0 mg/kg
PREDNISOLONE TREATMENTS UPON VI-15~ FOOD-REINFORCED
LEVER PRESSING
Introduction
Experiment nos. 4 and 5 indicated that acute prednisolone treatments were without effect upon a VI-15"
positively reinforced operant behavior regardless of the
type of appetitive reinforcer employed.

Experiment no.

6 showed that the pre-treatment interval could be varied
over a wide range and still an acute, high dose of prednisolone would remain without observable behavioral
effect in the aforementioned operant procedure.

One

important procedural difference between Experiment nos.
1 and 2 vs. Experiment nos. 4, 5 and 6 is that in the
former case prednisolone doses were repeated on a daily
basis over numerous consecutive days whereas in the
later case all doses of prednisolone were acute only.
It has been frequently suggested in the clinical literature that acute glucocorticoid doses, even when huge,
can be given without noticeable adverse impact but that
when repeated administrations are begun then drug-indueed toxicity quickly ensues.

Therefore, Experiment no. 7

was designed to investigate whether giving daily, repeated, high-dose prednisolone treatments would yield
102
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marked alteration of an established VI-maintained
operant response.

This study would thus possibly

resolve the discrepancy between the dramatic behavioral
influences observed in Experiment nos. 1, 2 and 3
(non-operant measures) and the virtual lack of behavioral effect found in Experiment nos. 4, 5 and 6
(operant measures).

Method
Subjects
Subjects were four female, adult Sprague-Dawley
rats (Subject nos. 339, 338, 374 and 394).

Subjects

were treated in all non-drug respects in a manner identical to that used in Experiment no. 4.
Apparatus
The apparatus was identical to that employed in Experiment nos. 4, 5 and 6.
Procedure
The procedure was identical to that employed in
Experiment no. 4, with the following exceptions.

Only a

single challenge dose level was selected (16 mg/kg) and
this dose was the same one used (and for the same rationale) as that used in Experiment no. 6.

The 16.0
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mg/kg dose level had been seen in Experiment nos. 1, 2
and 3 to yield unequivocal behavioral effects, when that
dosage was repeatedly administered.

In this and all

other "repeated" or "chronic" treatment operant experiments here described, daily drug injections were begun
once stability had been achieved in a manner previously
described (see Experiment no. 4).

Daily dosing continu-

ed until less than one response per minute occurred for
each subject.

Dosing was both initiated and terminated

on an individual-subjects basis.

The purpose of this

procedure was to ascertain operant behavioral effects
which accrued only with repeated, high-dose treatment.
For this particular experiment, VI-15" responding was
maintained with food reinforcement in accordance with
procedures outlined in Experiment no. 4.
Results
Figure 17 displays the effect of repeated, daily
prednisolone treatments (16.0 mg/kg, IM), over at least
15 days, upon VI-15" operant level pressing for food
re~nforcement.

Data are plotted for each animal separ-

ately, as percent of saline-control baseline (circles),
as a function of number of daily treatment sessions
(with drug administrations

i~dicated

by triangles).

Figure 17 clearly shows that for each and all of the
four subjects, behavioral effects of prednisolone were
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Figure 17:

The Effect of Repeated, Daily Prednisolone
Treatments (16.0 mg/kg, IM), for at Least
15 Days Upon VI-15 Sec. Operant Lever Pressing for 45 mg.
Rats.

Noyes Food Pellets, in Adult

Data are Plotted for Each Animal Sep-

arately, as Percent of Saline-Control Baseline (circles), as a function of Number of
Daily Treatment with Drug Administrations
Indicated by Triangles.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

120
100
eNaCI

80

• PREDNISOLONE
16 mg/kg

60

w
~
.J

40

RAT No. 339
m
IJ:l
-LL

0

.

0

I

I

I

I-. 120

.

I

I

I

I

I

I

I

I

I

I

I

I

3~':\~

••

z

w
u
a:: 100
w
Q.

I

RAT No.

0t,

\_.~

RAT No. 394

80

60
40

RAT No. ·374

20

0 I I

I

I. I

0

2

4

I

I

6

I

I

8

I

I

10

I

I .I

12

I

I

14

I

16

I

I

18

9

2

4

6

8

10

·12

14

16

18

DAILY SESSIONS

....

0

0'1

107

in evidence, and this effect upon operant responding
steadily accrued as the number of drug treatments
increased.
Discussion
Experiment no. 7 unambiguously demonstrated that
prednisolone treatments can dramatically alter VI-15"
food- maintained operant performance, but that the drug
must be given repeatedly in order for such effects to
emerge.

Experiment no. 7 thus corroborates the findings

of Experiment Nos. 1, 2 and 3 in that behavioral effects
increased with increasing number of treatments.

Experi-

ment no. 7 also corroborated the findings of Experiment
nos. 4, 5 and 6 in that initial (acute) treatments were
without appreciable behavioral influence.

This experi-

ment thus strongly suggests that the reason for lack of
behavioral effect in Experiment 4 was due to lack of
treatment chronicity.

This experiment thus largely

resolved the discrepancy between those results which had
obtained in non-operant vs. operant behavioral
pr9cedures.
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CHAPTER IX
EXPERIMENT VIII: INFLUENCE OF DAILY, REPEATED 16 mg/kg
PREDNISOLONE TREATMENTS UPON VI-15" WATER-REINFORCED
LEVER PRESSING.
Introduction
Experiment no. 7 demonstrated that prednisolone
·could indeed alter VI-maintained operant behavior, emplaying food as the reinforcer, if drug administration
was repeated rather than acute.

This resolved the

aforementioned discrepancies within the previous experimental findings of this line of research.

Experi-

ment no. 4 had employed VI-15" food-maintained responding to screen for acute effects and Experiment no. 7
indicated that no. 4's lack of effect had been due to
the "lack of chronicity" issue.

In Experiment no. 5,

water reinforcement had been used and it remained unclear as to whether repeated prednisolone treatments
could alter VI-maintained responding in a manner similar
to the way it had for food-maintained responding in
Experiment no. 7.

Therefore, Experiment no. 8 was

designed to assess the plausibility that chronic treatment effects could be obtained upon VI-15" water-reinforced operant behavior.

Such a demonstration would

further extend the findings of Experiment no. 7 to

108
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operant behavior maintained by a second type of appetitive reinforcer.
Method
Subjects
Subjects were four female, adult Sprague-Dawley
rats (Subject nos. 393, 334, 395 and 150).

All non-

drug, subject characteristics were similar to those
described in Experiment no. 5.

Apparatus.
The apparatus was identical to that employed in
Experiment nos. 4 through 7.
Procedure
The procedure was identical to that employed in
Experiment no. 7.

The sole exception was that instead

of food reinforcement and its attendant deprivation
procedure, water reinforcement was used.

The water

reinforcement procedure, and its attendant deprivation
procedure, are described in Experiment no. 5.

There-.

fore, a water-reinforced behavior was used, which was
maintained upon a VI-15" schedule of positive reinforcement.

Daily, repeated prednisolone drug treatments

(16.0 mg/kg, IM) were given following the usual establishment of behavioral stability.

Subjects were
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continued in the study until either 18 days of
continuous treatment had accrued or the rate of lever
pressing had fallen to less than one response per
minute.

Results
Experiment no. 8 demonstrated that repeated prednisolone treatments can markedly reduce VI-15" water
reinforced operant responding, and do so in much the
same way as was demonstrated in Experiment no. 7 for
food-reinforced VI responding.

The results of Experi-

ment no. 8 are displayed in Figure 18.

Here, data are

plotted for each animal separately, as percent of
saline-control baselines (circles) , as a function of
numbe~

of daily treatment sessions (with drug admin-

istrations indicated by triangles).

As can be seen,

response suppression generally accrued with increasing
number of drug treatments.

Marked variability emerged

both within and between subjects, yet for each subject
the response-suppression trend did appear.
Discussion
The results of this experiment are directly in
support of those found for the food-reinforced VI
responding of Experiment no. 7.

The water-reinforced

performances did appear to be a good deal more variable
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Figure 18.

The Effects of Repeated, Daily Prednisolone
Treatments (16.0 mg/kg, IM) Upon VI-15 Sec.
Operant Lever Pressing for 0.05 ml (ca.)
Draughts of Water, in Adult Rats.

Data are

Plotted for Each Animal Separately, as Percent of Saline-Control Baselines (Circles),
as a Function of Number of Daily Treatment
Sessions (With Drug Administrations Indicated by Triangles).

'.
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than those observed under the food-reinforcement schedule.

The limited number of observations precluded

further analysis of this issue, however.

In general,

the results of Experiment no. 8 further corroborate the
view that chronic, but not acute, glucocorticoid treatment will yield dramatic alterations in operant behavior.

Results of the present study also indicate that

the lack of behavioral effect noted in Experiment no. 5
was probably due to the "lack-of-chronicity" factor.
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CHAPTER X
EXPERIMENT IX: DOSE-RESPONSE EFFECTS OF ACUTE
PREDNISOLONE (0,2,4,8 and 16 mg/kg) UPON FR-20
MAINTAINED OPERANT BEHAVIOR FOR FOOD
REINFORCEMENT.
Introduction
Fixed-ratio (FR) schedules of reinforcement provide
for radically different patterns, as well as different
overall and local response rates, as compared to variable-interval schedules.

For this reason behavioral

pharmacologists often compare drug effects obtained on
any of various other schedules of reinforcement with
those obtained on FR positively reinforced behaviors.
Thus, in an effort to extend the discovery of prednisolone's effect upon operant behavior maintained on a VI
schedlule of reinforcement to other operant response
classes, FR-maintained behavior was challenged in the
present experiment.
FR schedules provide for the delivery of reinforcement immediately after a set, or fixed, number of responses have occurred.

Fixed-ratio schedules of posi-

tive reinforcement have also repeatedly proven to be
useful in assessment of a drug's operant behavioral
effects.

FR schedules have been used to assess psycho-

motor stimulants (e.g., Dews, 1958b; Owen, 1960;
114
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. Kelleher, Fry, Deegan, and Cook, 1961 J Kelleher a.nd
Morse, 1964J Smith, 1964i Rutledge and Kelleher, 1965;
McMillan, 1968a,b, 1969J Davis, Kensler, and Dews,
Byrd,

1973~

1973~

Barrett, 1974), antipsychotics (e.g.,

Paasonen and Dews, 1958; Waller, 1961J Kelleher, Fry,
Deegan and Cook, 1961; Cook and Kelleher, 1962; Kelleher
and Morse, 1964; Hanson, Witoslawski, and Campbell,
1967; Clark, 1969; McMillan, 1971; Leander and McMillan,
1974; Leander, 1975), antianxiety agents (e.g., Dews,
1955J Kelleher, Fry, Deegan, and Cook, 1961; Morse,
19627 Cook and Catania,

1964~

Waller and Morse, 1963;

Rutledge and Kelleher, 1965; Wedeking, 1968, 1974),
narcotic analgesics and narcotic antagonists (e.g. Cook
and Kelleher, 1962; McMillan and Morse, 1967; McMillan,
Wolf, and Carchman, 1970b; Thompson et al., 1970;
McMillan,

1971~

Holtzman and Villarreal,

1973~

Dykstra,

McMillan, and Harris, 1974) , tricyclic antidepressants
(e.g., Cook and Kelleher, 1962; Smith, 1964; McKearney,
1968), ethanol (e.g., Appel and Freedman, 1965), tetrahydrocannabinols (e.g., McMillan, Harris, Frankenheim
and Kennedy, 1970aJ Frankenheim, McMillan, and Harris,
1971; Dykstra, McMillan and Harris, 1975J Ferraro,
Grilly and Lynch,

1~71),

cholinergic blockers (e.g.

Dews, 1955; Boren and Navarro, 19597 Willis and
Windland, 1968; Bignami and Gatti, 1969), and
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cholinergic agonists (e.g. Morrison,
1970~

1967~

Pradhan,

Davis, Kensler, and Dews, 1973).
Method

Subjects
Subjects were three female, adult Sprague-Dawley
~ats

(Subject nos. 130, 134 and 129).

Subjects were

maintained and handled in all respects similar to those
employed in Experiment no. 4, which also used food
reinforcement and deprivation procedures.
Apparatus
The apparatus was identical to that employed in
Experiments no. 4, S, 6, 7 and 8.
Procedure
The procedure was identical to that used in Experiment no. 4, except that instead of a VI-15" reinforcement pro cedure having been in effect, a FR-20 reinforcement procedure was used.

As mentioned in the In-

troduction to this experiment, FR schedules require that
after a preset (fixed) number of responses have occurred
the reinforcing event is then immediately delivered.
Thus, lever-pressing was reinforced after every 20th
response had occurred.

The drug administration proced-

ure was also identical to that employed in Experiment
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no. 4, including the aspect of each subject having been
challenged with each dose level twice.
Result
Figure 19 displays the effects of acute prednisolone treatments (2,4,8 and 16 mg/kg, IM) upon FR-20
lever- pressing for 45 mg Noyes food pellets, in three
adult rats.

Data are plotted individualiy for each

subject, as percent of saline-control baseline, as a
function of prednisolone dose.

Each subject received

all doses twice, with both the high and low values
plotted around each mean.

In general, Figure 19 shows

that no main effect emerged of acute prednisolone dose,
in any of the three subjects tested.
Discussion
The results of Experiment no. 9 directly parallel
those found for VI-maintained responding in Experiment
no. 4.

Together then, Experiment nos. 4 and 9 indicate

that the lack of acute prednisolone effect upon foodreinforced operant lever pressing does not seem to
•
depend upon the type of positive reinforcement schedule
used to maintain the operant response.

These findings

emphasize the fact that acute glucocorticoid treatments,
even at large doses, are unlikely to yield behavioral
influence.
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Figure 19.

The Effects of Acute Prednisolone Treatments (2,4,8 and 16 mg/kg, MI) Upon FR-20
Lever-Press Responding for 45 mg Noyes
Food Pellets, in Three Adult Rats.

Data

are Plotted Individually for Each Subject,
as Percent of Saline-Control Baseline as
a Function of Prednisolone Dose.

Each

Subject Received All Doses Twice, with Both
the High and Low Values Plotted Around
Each Mean.

\
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CHAPTER XI
EXPERIMENT X: DOSE-RESPONSE EFFECTS OF ACUTE
PREDNISOLONE (0,2,4,8 an 16 mg/kg) UPON
FIXED RATI0-20 MAINTAINED OPERANT BEHAVIOR
FOR WATER REINFORCEMENT.
Introduction
Experiment no. 9 showed that acute prednisolone
treatment was without observable effect upon FR-20
food-reinforced operant responding.

These results were

in keeping with those previous findings of acute prednisolone challenge upon VI performance for food reinforcement (Experiment no. 4) as well as VI performance
for water reinforcement (Experiment no. 5).

It remained

unclear, however, as to whether acute prednisolone
treatment would alter operant behavior maintained by an
FR-20 schedule for water reinforcement.

Experiment no.

10 was thus conducted to assess this possibility.
Method
Subjects
Three adult, female Sprague-Dawley rats served as
subjects (Subject nos. 277, 279 and 280).

Subjects were

maintained and handled in a manner identical to that
described in Experiment no. 5.

120
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Apparatus
The apparatus was identical to that described in
Experiment no. 4, and employed in Experiment nos. 4-9.
Procedure
The behavioral training and testing procedure was
identical to that which was used in Experiment no. 9.
The FR-20 schedule was used to engender stable behavior
rates.

The reinforcement was water, and the water dep-

rivation procedure was similar to that described in
Experiment no. 5.

Drug treatments preceded in a manner

identical to that which occurred in Experiment nos. 4, 5
and 9.

In this experiment, however, each subject was

exposed to each dose level of prednisolone only once.
Results
Figure 20 displays the influence of acute prednisolone treatments (2,4,8 and 16 mg/kg, IM) upon FR-20
operant lever-pressing for 0.05 ml draughts of water
reinforcement, in each of three adult rats.

Data are

plotted individually for each subject, as percent of
saline-control baseline, as a function of prednisolone
dose.

As can be seen in Figure 20, the behavior of none

of the three subjects showed any appreciable effect of
the acute drug challenge.

In fact, behavior remained

strikingly stable throughout the experiment.
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· Figure 20.

The Influence of Acute Prednisolone Treatments (2,4,8 and 16 mg/kg, IM) Upon FR-20
Operant Lever-Press Responding, for 0.05 ml
(ca.) Draughts of Water Reinforcement, in
Three Adult Rats.

Data are Plotted Indivi-

dually for Each Subject, as Percent of
Saline-Control Baseline as a Function of
Prednisolone Dose.

Each Subject Received

all Doses Once.
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Discussion
Experiment no. 10 demonstrated a total lack of observable behavioral effect of acute prednisolone treatment upon FR-20 water-reinforced lever-press responding.
These results were wholely in keeping with those obtained for VI responding maintained by either food or water
reinforcement, and for FR responding for food reinforcement.

Collectively, Experiment nos. 4, 5, 9 and 10

indicate that acute prednisolone, even at high doses is
without appreciable operant behavioral effect, regardless of the positive reinforcement schedule in effect or
the type of appetitive reinforcer used.
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CHAPTER XII
EXPERIMENT XI: INFLUENCE OF DAILY, REPEATED 16 mg/kg
PREDNISOLONE TREATMENTS UPON FR-20 WATER
REINFORCEMENT
Introduction
All attempts to deliver acute prednisolone challenge to operant behavior maintained by either FR or VI
reinforcement schedules, incorporating either food or
water as the response consequence, led to a remarkable
lack of effect.

Repeated prednisolone treatment, how-

ever, had in both previous cases (i.e. VI for food, VI
for water) yielded clear evidence of behavioral suppression.

Furthermore, this response suppression had, in

general, clearly increased with increasing number of
drug treatments.

Given that both of the repeated treat-

ment experiments employing operant baselines had involved a VI reinforcement schedule, it was thought that
a behavior maintained by an FR schedule should also be
analyzed as to its sensitivity to repeated prednisolone
adroinistration.

Therefore, Experiment no. 11 implement-

ed an FR-20 schedule for water reinforcement, and upon
the operant response so generated, examined the influence of daily, .repeated prednisolone treatment (16
mg/kg, IM).
125
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Method
Subjects
Subjects were three adult, female Sprague-Dawley
rats (Subjects no. 170, 372, and 350).

All subject

characteristics, including deprivation schedules, were
similar to those outlined in Experiment no. 4.
Apparatus
The apparatus was identical to that employed in
Experiments no. 4-10.
Procedure
The drug administration procedure was similar to
that outlined in Experiment nos. 7 and 8.

In brief,

after stability was achieved, daily drug administrations
were begun and then continued until either a set number
of days.had passed (in this case, 17), or the animal's
response rate had fallen to a rate of one response per
minute or less.
The behavioral procedure was identical to that
which had been incorporated into Experiments no. 9 and
10.

In brief, an FR-20 schedule of positive reinforce-

ment was used.

The response consequence in this case

was water.
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Results
Figure 21 presents the effects of repeated daily,
prednisolone treatments (16.0 mg/kg, IM), upon FR-20
operant lever-press responding for 0.05 ml draughts of
water reinforcement, in three adult rats.

Here, the

data are plotted for each subject separately, as
percents of saline-control baselines (circles), as a
function of number of daily treatment sessions (with
drug administrations indicated by triangles).

As can be

seen in the figure, for each of the three subjects as
the number of drug treatments increased so too did the
degree of response suppression.
Discussion
Experiment no. 11 showed that for FR-maintained responding -- just as had previously been found the case
for VI-maintained behavior -- as the number of prednisolone treatments went up, so too did the degree of response suppression.

This generalization thus appears to

hold regardless of reinforcement schedule or type of
appetitive reinforcer involved.

In all of the "chronic

treatment" operant studies examined thus far, earlier
administrations appeared to have produced far less of an
effect than was the case for later administrations.
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.Figure 21.

The Effect of Repeated, Daily Prednisolone
Treatments (16.0 mg/kg, IM), Upon FR-20
Operant Lever-Press Responding for 0.05 ml
(ca.) Draughts of Water Reinforcement, in
Three Adult Rats.

Data are Plotted as Per-

cent of Saline-Control Baseline (Circles),
as a Function of Number of Daily Treatment
Sessions _(with

~rug

Administrations Indicat-

ed by Triangles).
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CHAPTER XIII
EXPERIMENT XII: ANALYSIS OF DAILY, REPEATED PREDNISOLONE UPON DIFFERENTIAL REINFORCEMENT OF LOW RATE 15" (DRL-15) FOOD REINFORCED OPERANT BEHAVIOR EXAMINED
IN DAILY TEST SESSIONS CONDUCTED 30 MINUTES AFTER
INJECTION
Introduction
Experiments no. 4-11 examined prednisolone's impact
(both acute and chronic) upon either FR-20 or VI-15"
operant responding.

One important objective of the

current line of research was to expand as much as
possible the number and variety of drug-behaviorenvironment situations so as to generate a "profile" of
prednisolone's behavioral action.

For this reason, it

was decided to further examine the influence of repeated
prednisolone treatments by constructing operant behavior
maintained by DRL-15" reinforcement contingencies.

DRL

responding (also known as "inter-response time greater
than X", or alternately, IRT X") is additionally useful
in drug screening procedures since it engenders very low

•
response
rates, and thus, assays which employ DRL schedules may uncover drugs selectively influential with
respect to· this property.

Experiment no. 12 thus es-

tablished operant responding under a DRL-15" schedule of
food reinforcement, so as to extend the range of operant·

130
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schedules upon which prednisolone's behavioral effects
might be screened.
A second general objective of Experiment no. 12 was
to establish whether the response suppression which had
accrued as a function of number of drug treatments in
Experiments no. 7, 8, and 11 was in fact attributable to
a steadily growing, generalized behavioral debilitation
or to an increasing degree of behavioral sensitization
to the drug's influence.

Therefore, Experiment no. 12

required that 30-minute test sessions be conducted both
before and after daily drug administrations.

In this

way, the pre- and post-administration sessions could be
directly compared on a daily basis to ascertain whether
the "debilitation hypothesis" was the more tenable.

To

the extent that pre- and post-administration sessions
demonstrated response suppressions at approximately the
same rates then it could be concluded that subjects were
experiencing a growing behavioral debilitation as the
number of drug treatments increased.

On the other hand,

to the extent that the pre- and post-treatment sessions
diverged as regards to the suppression rate - and in
particular if the post-sessions yielded a rate of suppression onset and suppression magnitude were substantially greater than the pre-sessions did

then this

outcome would argue for the "sensitization hypothesis."
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Differential reinforcement of low rate (DRL)
schedules reinforce only a single response that occurs
after the lapsing of a pre-set, fixed, interval.

In

addition, no responses are to have occurred during the
interval.

If a response does occur, then the interval

is re-set and the timing starts over.

In this way, only

responding which occurs after minimum "inter-response
times", or greater, are reinforced.

DRL schedules have

been used to assess drug effects on operant responses
which occur at comparatively low rates.

DRL schedules

have also been employed with numerous classes of drugs
including psychomotor stimulants (e.g., Sidman,
Kelleher, Fry, Deegan, and Cook,
1967~

McMillan and Campbell,

Blackman,

1974~

1961~

1970~

1955~

Hearst and Vane,

Sanger, Key and

MacPhail and Gollub, 1975), anti-

psychotics (e.g. Kelleher, Fry, Deegan, and Cook,

1961~

Sanger and Blackman, 1975a), antianxiety agents (e.g.,
Kelleher, Fry, Deegan, and Cook,

1961~

Morse,

Richelle, Xhenseval, Fontaine, and Thone,
and Campbell,

1970~

1962~

1962~

Sanger, Key, and Blackman,

McMillan
1974~

Sanger and BLackman, 1975a), tricyclic antidepressants
(e.g. Kornetsky, 1965), ethanol (e.g., Sidman,
Laties and Weiss,

1962~

1955~

Hoolway and Vardiman, 1971),

hallucinogens (e.g., Appel, 1971), tetrahydrocannabinols
(e.g., Frankenheim, McMillan, and Harris,
Grilly, and Lynch,

1971~

1971~

Ferraro,

Conrad, Elsmore, and Sodetz,
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1972: Manning, 1973: Frankenheim, 1974), and cholinergic
agonists (e.g., Morrison, 1968: Pradhan and Dutta,
. 1970) •
Method
·subjects
Six subjects served in this experiment.

All

subjects were adult, female Sprague-Dawley rats which
had been bred and raised in the laboratory's colony.
Subjects were similar in all respects to those animals
employed in Experiments no. 4, 7, and 9.
Apparatus
The apparatus· was identical to that employed in
Experiments no. 4 through 11..
Procedure
A DRL-15" schedule of positive reinforcement, which
involved food delivery as the response consequence,
served to maintain the operant lever-press response (see
Introduction to Experiment no. 12 for further description of DRL procedures in general) •
DRL behavioral test sessions were conducted both 30
minutes before and 30 minutes after daily drug administrations.

During the baseline stability phase of the

experiment, each subject was studied daily in the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

134

above-stated procedure.

At this time, only saline-

vehicle was administered.

Once stability was achieved

according to the manner described in Experiment no. 4,
actual prednisolone treatments were begun and then
continued on a daily basis.

Four of the subjects were

randomly assigned to the 16.0 mg/kg dose condition while
two of the subjects were assigned to the 32.0 mg/kg dose
level.

All subjects were studied for a minimum of 8

treatment days.
Results
Figure 22 displays the influence of repeated daily
administrations of either 16.0 mg/kg or 32.0 mg/kg IM
prednisolone treatments upon operant responding maintained under a DRL-15" reinforcement schedule yielding
45 mg food pellet response consequences.

For each of

the six subjects, saline-control sessions are graphed as
Sessions no. 1-4 (i.e. to the right of each dotted
line), and prednisolone- treatment sessions are graphed
to the right of each dotted line.

For each day, circles

in9icate pre-injection sessions and triangles indicate
post-injection sessions.

Inspection of Figure 22

reveals that for each and all of the six subjects - as
the number of drug treatments increased so to did the
degree of response suppression.

Furthermore, this

process appeared to be somewhat more accelerated for the
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Figure 22.

The Influence of Repeated, Daily Administrations of Either 16.0 or 32.0 mg/kg, IM.,
Prednisolone Treatments Upon Operant Responding Maintained Under a DRL-15" Reinforcement Schedule for 45 mg Noyes Food
Pellets.

Behavioral Testing Sessions (30

Minutes Each) were Conducted Twice Daily for
Each Subject, One Being Initiated 30 Minutes Before Administrations and the Other
Initiated 30 Minutes After

Inje~tions.

For

Each of the Six Subjects, Saline-Control
Sessions are Graphed as Sessions #1-4 (i.e.
to the Left of Each Dotted Line), and Prednisolone-Treatment Sessions are Graphed
to the Right of Each Dotted Line.

For Each

Day, Circles Indicate Pre-injection Sessions
and Triangles Indicate Post-injection
Session.
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32 mg/kg subjects than was the case for the 16 mg/kg
animals.
As regards the "debilitation hypothesis" versus the
"sensitization hypothesis", the data lend some support
to both views.

For two of the 32 mg/kg subjects, and

for both the 16 mg/kg animals in later sessions, the
post-administration sessions clearly evidenced a greater
degree of response suppression than did the pre-administration sessions.

In only one of the 32 mg/kg subjects,

however, did the post- injection response rates sharply
diverge from the pre-injection response rates.

For the

remaining two 16 mg/kg animals no clear separation of
the two response-rate curves ever became evident.
Discussion
Experiment No. 12 revealed several interesting
facts regarding prednisolone's behavioral action.
First, DRL is yet another operant reinforcement schedule
that can engender response baselines sensitive to prednisolone's behavioral effects.

Second, acute treatments

yield no appreciable impact upon DRL-maintained responding.

Third, even when a DRL schedule is employed pred-

nisolone's operant behavioral action can still be unequivocally described as that of response rate suppression.

And, third, this response suppression appears to

be, in part, the product of both an increasing
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behavioral debilitation and an increasing behavioral
sensitization to prednisolone's influence.
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CHAPTER XIV
EXPERIMENT XIII: INFLUENCE OF DAILY, REPEATED PREDNISOLONE (0,8,16 and 32 mg/kg) UPON ACQUISITION OF
FREE-OPERANT (SIDMAN) AVOIDANCE, AS ASSESSED BY AVERAGE
NUMBER OF SK-SK, R-SK, AND RESPONSES DISPLAYED PER
GROUP.
Introduction
Collectively, Experiment nos. 4-12 strongly indicate that prednisolone can markedly alter operant
responding but that this behavioral action is exerted
only if drug treatments are repeated numerous times.
This conclusion regarding prednisolone's behavioral
activity is based upon experiments involving VI, FR and
DRL appetitive reinforcement schedules.

It is of both

behavioral and pharmacological relevance to examine the
extent to which prednisolone can also alter operant
behavior maintained by stimuli other than appetitive
reinforcers.

Experiment no. 1 employed a hot- plate

assay of nocioceptive reactions for subjects which had
received twelve daily treatments of prednisolone.

In

this assay prednisolone appeared to be somewhat active-'somewhat' in the sense that the results approached but
did not meet statistical significance.

These results,

combined with the activity observations of Experiment
no. 2, do at least suggest, however, that operant
behavior maintained by aversive control procedures might
139
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also be altered under repeated prednisolone treatment.
For the conduct of Experiment no. 13, free-operant
(Sidman, or, unsignalled) avoidance (e.g. Sidman, 195Sa;
Sidman, 1958b) was thus selected as a behavioral control
procedure with which to analyze the influence of this
drug upon a negatively reinforced response.

Thus, the

primary purpose of Experiment no. 13 was to extend the
generality of prednisolone's operant behavioral effects
to include influences upon aversively motivated instrumental behaviors.
A second purpose of Experiment no. 13 was to examine the extent to which prednisolone might alter the
acquisition of an operant.

Heretofore (i.e., Experiment

nos. 4-12) the current line of research had only explored the drug's influence on those operant responses which
had already been learned.

Experiment no. 3 examined the

effect of prednisolone functioning as the UCS in the
conditioned taste aversion paradigm, and thus assessed
the extent to which the drug might participate in a
respondent learning process.
pr~viously

However, none of the

described experiments examined the influence

of prednisolone upon an ongoing learning process.
A third rationale for the conduct of Experiment no.
13 had more to do with procedural development.

Tradi-

tionally, Sidman avoidance has been conducted in the
standard operant conditioning chamber and involved the
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standard response lever as the operant manipulandum.
Such a procedure typically does require hand-shaping of
the repertoire, and in addition many subjects appear to
require large amounts of time and exposure with respect
to the contingencies before steady-state unsignalled
avoidance is finally achieved.

Therefore, traditional

Sidman avoidance has been unsuitable for drug studies of
the response acquisition process.

On the other hand,

signalled avoidance has typically been carried out in
the so-called shuttle box.

The required response simply

involves the subject running or 'shuttling' from one
side of the apparatus to the other.

No hand shaping is

required, most subjects finally acquire the necessary
activity, and thus the technique is useful for analysis
of drug e·ffects upon avoidance acquisition.

The problem

with the signalled avoidance paradigm, however, is that
the free-operant rate of behavior is an obscured variable due to the delimiting nature of the discrete--trial
procedure.

This is a marked problem since, for among

other reasons, if the subject is already a highly effe9tive avoidance performer it has reached a "ceiling"
and thus avoidance-enhancing drug effects can not be
observed.

Furthermore, in discrete-trial avoidance

there are always a number of subjects who simply never
acquire the response.

For these reasons, Riess and

Farrar (1972) developed a procedure whereby Sidman
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avoidance contingencies are incorporated with the shuttlebox apparatus and its attendant requirement of the
running response as an operant which thus yields a high
efficency, rapid acquisition procedure.

Drug effects

can thus quite plausibly be examined in this paradigm
for their influences upon the parameters of avoidance
response learning.

Surprisingly, this tactic has been

neither adopted nor even suggested.

As such, a third

purpose of Experiment no. 13 was to assess the feasibility of employing the Riess and Farrar (1972) avoidance procedure in the screening of this drug's effect
upon the acquisition of a negatively reinforced
response.
Free-operant avoidance has frequently been employed
to analyze the influence of various chemical agents upon
negatively reinforced operant behavior.

Procedural de-

scriptions of free-operant (also known as "continuous
avoidance" or "Sidman avoidance" -- so named after it's
progenitor) avoidance involve specification of both a
response-to-shock (R-S) and a shock-to-shock (S-S)
in~erval.

In general, the R-S interval is considerably

longer than the

s-s

interval.

In this way, there exists

considerable 'payoff' for the performing organism in
that occurrence of the scheduled aversive event is considerably delayed if a response occurs.

As long as the

subject continues to respond before the R-S times out,
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'

the aversive event does not occur and instead is rescheduled into the future according the the pre-set R-S
interval.

To the extent that a response does not occur

within the pre-set period, a shock does occur with the
then ensuing shock to occur after a relatively short
interval.

s-s

Such periodic deliveries then repeat until

yet another response occurs reinstating the R-S interval.

Sidman avoidance has been employed to assess the

influence of many variables, including drugs.

A very

desirable feature of Sidman avoidance, as a baseline, is
that the rate of avoidance can vary over a wide range
while still remaining rather effective with respect to
the contingencies.

Thus, Sidman avoidance procedures

possess a decided advantage over the older, discretetrial avoidance procedures (also known as Hoffman
avoidance, after it's progenitor).

The following drug

classes have been examined using Sidman avoidance:
psychomotor stimulants (e.g., Verhave,
1959~

Heise and Boff,

Boff,

1964~

Ke~sler,

1962~

Stone,

1964~

Pearl, Aceto, and Fitzgerald,

and Dews,

1973~

1962~

Cook and Kelleher,

Scheckel and Boff,

1964~

Weissman,

Schekel and
1968~

Davis,

Houser, 1973), antipsychotics

(e.g., Boren, 196lb, Clark and Steele,
Boff,

1958~

1962~

1963~

Stone,

Heise and
1964~

Hanson, Stone, and Witoslawski,

1967, 1970; Niemegeers, Verbruggen, and Janssen, 1969),
antianxiety agents (e.g., Randall, Schallek, Heise,
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Kieth, and Bagdon,

1960~

1962~

Heise and Boff,

Cook and

Kelleher, 1962~ Bignami,'deAcetis, and Gatti, 1971),
narcotic analgesics and narcotic antagonists (e.g. Heise
and Boff,
Jewett,

1962~

Cook and Kelleher,

1972a,b~

1962~

Holtzmann and

Steinert, Holtzman, and Jewett,

1973~

Hotzman, 1974a,b,c,d), tricyclic antidepressants (e.g.
Heise and Boff,
and Boff,

1962~

1964~

1963~

Cook and Kelleher,

Owen and Rathbun,

1966~

Scheckel

Molinengo and

Ricci-Gamalero, 1972), ethanol (e.g. Heise and Boff,
1962~

Reynolds and van Sommers, 1960), hallucinogens

(e.g. Jarrard,

1963~

(e.g. Herrnstein,
and Boff,

1964~

Wray, 1972), cholinergic blockers

1958~

Heise and Boff,

1962~

Scheckel

Stone, 1964), and cholinergic agonists

(e.g. Pradhan, 1970).
Method
Subjects
Twelve adult, male Sprague-Dawley rats served as
subjects.

All rats were bred and raised in the labora-

tory's colony.

Subjects were individually housed under

conditions described in Experiment no. 4.

Purina Rode~t

Chow and water remained continuously available to all
subjects while in their home cages.
Apparatus
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The behavioral test apparatus consisted of a standard BRS shuttle-box (23cm X 20cm X 19cm) constructed of
steel walls and grid floor which could be electrified
and acrylic portal windows and ceiling.

Control of test

sessions and collection of all data were accomplished
via conventional electromechanical equipment.

Movements

of the subject from one end to the other of the shuttlebox (movement here termed the 'shuttle response') caused
a slight tilt in the floor, thus activating a microswitch.

Gridfloor shock was delivered on a scrambled

basis on all occasions.
Procedure
The twelve subjects were divided up into four
groups of three subjects each (N=3/group) wherein each
group was randomly assigned to a different dose level of
prednisolone (0.0, 8.0, 16.0 or 32.0 mg/kg).

All in-

jections were administered intramuscularly at a volume
of 1.0 ml/kg.

For each group, the selected drug dose

was administered on five successive days.
da~ly

After this,

avoidance sessions were conducted for the ensuing

10-day period.

All animals were exposed to the follow-

ing invariant shock parameters and behavioral contingencies:

SK-SK = 2.0 sec.; R-SK = 20.0 sec.; shock

duration= 0.5 sec.; shock intensity= 0.8 mAmp.
sessions were 30 minutes in length.

All

At the end of the
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Figure 23.

The Effects of Repeated, Daily Prednisolone
(0,8,16 and 32 mg/kg, IM)

(N=3/Dose Group)

Upon Acquisition of Sidman Avoidance (S-S =
2.0"; R-S = 20.0"; Shock Duration = 0.5";
Amplitude = 0.8 mAmp) Programmed for a Shuttle-Box.

Subjects were Assigned to the

Various Dose Groups, Treated for Five Consecutive Days, then Exposed to Sidman Avoidance Sessions (30 Minutes Each) for the
Ensuing 10 Days.

Data are Plotted as Aver-

age Numbers of Responses, Shock-to-Shock
Intervals, and Response-to-Shock Intervals
Taken by Each Group Across the Ten Days of
Contingency Exposure.
\·"
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10-day training period, the average number of responses
performed, as well as the number of shock-to-shock and
response-to-shock intervals experienced, were calculated
for each group and plotted.
Results
Figure 23 presents the effects of repeated, daily
prednisolone (0,8,16 and 32 mg/kg, IM)

(N=3/group) upon

acquisition of Sidman avoidance programmed for a shuttle-box.

Data are plotted as average number of respon-

ses, shock-to-shock intervals, and

~esponse-to-shock

intervals taken by each group across the ten days of
contingency exposure.

As. can be seen in Figure 23,

avoidance acquisition did indeed depend upon dose of
prednisolone treatment.
affected, however.

All parameters were not equally

No clear differences emerged for the

'response' dependent measure, however, 'SK-SK intervals
experienced' and to a lesser extent 'R-SK intervals experienced' were impacted upon.

For the SK-SK parameter,

the 8.0 and 16.0 dose levels clearly and dramatically
de9reased the number of SK-SK intervals experienced.
Since 'SK-SK intervals taken' is often used as a gauge
of the degree of Sidman avoidance acquisition, it could
be stated that exposure to 8.0 or 16.0 mg/kg actually
had a facilitative effect upon free-operant avoidance
acquisition.
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Discussion
Several points bear brief mention regarding the
outcomes of Experiment no. 13.

First, prednisolone did

clearly alter an aversively motivated response.

Second,

this drug did clearly impact upon the acquisition, or
learning, of an operant behavior.

Third, the procedure

introduced by Riess and Farrar (1972) does appear to be
very effective and efficient for the screening of drugs
as to their potential influence on free-operant avoidance - both in its acquisition phase and in its terminal
steady-state.

The findings of Experiment no. 13 thus

corroborate the suggestion gained from Experiment no. 1
that prednisolone is behaviorally active in aversively
motivated response systems.

This might have been an-

ticipated in part by the potential role which glucocorticoids now seem to have in certain endorphin- related
functions (see the General Discussion for further analysis of this issue).

Finally, this experiment extends

previous studies which have examined correlations betw~en

free-operant avoidance and pituitary-adrenal

function (e.g. Sidman, Mason, Brady and Thach,

1962~

Wertheim, Conner and Levine, 1967) in that further evidence is provided that the glucocorticoids do have a
clear impact upon the acquisition and elaboration of
aversively motivated behaviors.
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CHAPTER XV
GENERAL DlSCUSSION
Daily prednisolone yielded decrements in water intake which accrued both as a function of drug dose and
number of treatments.

Also observed was a significant

interaction between these two variables (Figures 1,6 and
11).

One potential mechanism may reside with known glu-

cocorticoid effects on electrolyte balance (Haynes and
Murad, 1980) •

Glucocorticoid treatment yields sodium

reabsorption in the kidney's distal tubules (Haynes and
Murad, 1980) •

High levels of glucocorticoids also re-

duce sodium concentration and sodium/potassium ratios in
vivo dialysate of stool (Richards, 1969).

Therefore,

marked sodium retention occurs by both renal and gastrointestinal processes.

As sodium is retained, water

passively follows and extracellular fluid volumes rise
(Haynes and Murad, 1980) •

Anti-diuretic hormone (ADH)

synthesis and release mechanisms may also be activated
yi~lding

1979).

further renal re-absorption of water (Guyton,
Thus, cortisol typically enhances total body

water, most often in the extracellular space, but on
occasion in intracellular compartments also (Ziff,
Simson, Bunim, 1952) •

In contrast to cortisol and

corticosterone, prednisolone and prednisone yield
150
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comparatively weak sodium retention, yet clinically
evident edema occurs and particularly with high doses
(e.g., Mills, 1985).

Prednisolone- induced increases in

extracellular volumes may thus yield prolonged suppression of drinking by altering volumetric thirst mechanisms.

These mechanisms have been analyzed (Fitzsimons,

1961; Gilbert and Glaser, 1961; Stricker, 1969;
Tepperman, 1980).
Both the 16.0 and 32.0 mg/kg subjects demonstrated
a partial return toward baseline intake during latter
days (Figures 1,6 and 11).

The significance and causal

mechanism of such effects remains unclear.

It is pos-

sible that volume receptor activity became adapted and
thus yielded a decline in both ADH release and the typical renal sequela to ADH release (Guyton, 1979).

Alter-

nately, extended glucocorticoid treatment can yield both
shifts in the internal distribution of water by altering
membrane's permeability to water (Mills, 1965) and increased renal free water clearance (Dingham, 1961).
Additionally, intake modulation may occur via direct
action of glucocorticoids on the CNS, perhaps at the
level of the hypothalamus, as extensive binding of glucocorticoids upon CNS tissues has been demonstrated
(Feldman, 1973; McEwen, 1973).
Daily prednisolone treatment produced dose-related
systemic toxicities, as indexed by marked decrements in
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total body mass.

Weight loss accrued with number of

drug treatments, and a dose by treatments interaction
was demonstrated (Figures 2, 7 and 13).

Although

Cushingoid patients typically present mild to dramatic
weight gains, various reports have indicated weight loss
subsequent to glucocorticoid treatment in laboratory
animals (Katz and Carroll, 1978; Kendall, 1970; Leshner,
1971; Loeb,

1976~

Nelson, 1980).

In this catabolic

effect, glucocorticoid actions appear to be multiple, or
at least to affect multiple systems.
Well-known are glucocorticoid effects upon protein
metabolism (e.g., Baxter and Forsham,

1972~

Loeb, 1976).

Decrements in protein stores occur for almost all tissues except liver (Guyton, 1979), along with increased
mobilization of amino acids from extrahepatic tissues
(Haynes, and Murrad,

1980~

Parson, Crispell, and Ebbert,

1952), skeletal muscle wasting (Haynes and Murrad,

1980~

Siber and Porter, 1953), and a negative nitrogen balance
(Siber and Porter, 1953) due in part to amino acid deamination (Baxter and Forsham,
Eb9ert, 1952).

1972~

Parson, Crispell, and

Also, high circulating glucocorticoid

levels produce inhibition of protein synthesis (Baxter
and Forsham, 1972; Clark, 1953), possibly related

t~

observed decrements in extrahepatic RNA formation
(Guyton, 1979) and/or amino acid uptake (Baxter and
Forsham,

1972~

Clark,

1953~

Lawrence and MacVicar,
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1954)..

In the present experiments, postmortem inspec-

tions revealed marked wasting of skeletal muscle in
drug-treated subjects.

Altered protein metabolism is

thus suggested as one important mediator of the prednisolone-induced weight losses here reported.
A second plausible mechanism of the present weight
losses may involve a drug-induced abatement of growth.
Widespread inhibition of growth has been reported for
both child (Blodgett, Burgin, Iezzoni, Gribetz, and
Talbot, 1956; Falliers, Tan, Szentivanyi, Jorgenson, and
Bukantz, 1963; Liddle and Melman, 1974; Thomas and
Mawhinney, 1973) and immature laboratory animal (Wells
and Kendall, 1940) recipients of glucocorticoid therapy.
In these, prolonged high-dose glucocorticoids have produced decreased height, body mass, and skeletal maturity
(Blodgett, Burgin, Iezzoni, Gibetz, and Talbot, 1956).
Glucocorticoid treatment may result in premature closure
of the epiphysical plates of long bones, thus yielding
an irreversible shortening of stature (Liddle and
Melman, 1974).

In qddition, osteoporosis occurs (Liddle

and Melman, 1974; Thomas and Mawhinny, 1973), probably
as a consequence of anabolism and anti-catabolism of
bone's protein matrix (Guyton, 1979).

Inhibition of

growth hormone secretion follows glucocorticoid treatment, yet because replacement therapy does not restore
growth, little relevance has been assigned this sequela
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(Baxter and Forsham, 19721 Morris, Jorgensen, Elrick,
.and Goldsmith, 1968).

Subsequent to glucocorticoid ad-

ministration, decreased cell division and DNA synthesis
have been documented across various tissues (Haynes and
Murad, 1980), with effects particularly evident where
cell proliferation represents accremental, as opposed to
turn-over, growth (Loeb, 1976).

Exactly how these ef-

fects are mediated remains obscure (Haynes and Murad,
1980).

In the present study Experiment no. 1 employed

30-day old weanling rats1 organisms in which very rapid
growth occurs (with a doubling of body mass in about 2
weeks)

(Loeb, 1976) •

Thus, the marked differences in

weight across groups noted in Experiment no. 1 might
have been in part a function of the arresting of growth
in the prednisolone-treated subjects.

This growth

abatement effect was likely largely irrelevant as
regards the mature subjects of Experiment nos. 2 and 3.
Still other hypothesized mediators of prednisolone's body weight effects involve modification of
intake and excrement processes.
be~n

Already discussed has

this drug's effect on water intake as shown in our

assay.

Clear dose-related decrements in water-intake

were noted, and it is plausible that this adipsia contributed to overall losses in body mass.

Another line

of evidence suggests that glucocorticoid-induced alterations in food intake also contributed.

Severe calorie
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deprivation induces increased levels of circulating
glucocorticoids with a resultant decreased rate of
somatic growth noted in immature laboratory animals and
children· (Prader, Tanner, and von Harnack, 1963).

Sec-

ond, adrenalectomy decreases food intake, and glucocorticoid replacement therapy restores intake to control
levels (Leshner, 1971).

Third, patients receiving glu-

cocorticoid therapy for palliation of various chronic
disease states demonstrate marked enhancements of appetite following therapy onset (Baxter and Forsham,
1972).

The interpretation of this latter evidence is

clouded, however, as alleviation of the disease state
per se might alter intake patterns.

Direct analysis of

exogenous corticosterone effects upon feeding by laboratory animals has revealed a bitonic function.

Low

doses of corticosterone stimulate, while high doses suppress, food intake (Panksepp, 1975; Van Putten, Van
Bekkum, and Querido, 1953).

Panksepp (1975) bas spec-

ulated that low doses induce hyperglycemia which in turn
yields insulin secretion and increased feeding, while
hiqh doses induce profound hyperglycemia and a resultant
cessation of feeding.

Experiment no. 2 did indeed dem-

onstrate marked hyperglycemia under repeated glucocorticoid treatment.

As prednisolone is at least 3-4 times

more potent than the naturally occurring glucocorticoids
with respect to carbohydrate metabolism effects (Haynes
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and Murad, 1980), it is likely that the dose range
employed in the present study rests more on the aphagic
extreme of this bitonic function.

Direct observations

of food intake under prednisolone treatment are required
for further analysis.

And finally, Experiment no. 3 did

demonstrate conditioned taste aversion, and this mechanism may have also contributed to the weight losses via
decrements in food intake.
Prednisolone displayed selective effects in both
across-organ and relative-organ weight comparisons
(Figures 3 and 9) •

Absolute gonadal weights were

depressed in a dose-related fashion for drug-treated
versus control subjects in Experiment no. 1.

Yet when

gonad-to-total body weight ratios were examined, the
testes were found to be relatively insensitive to
glucocorticoid effects.

This latter result is in

keeping with reports describing the testes as 'glucocorticoid-resistant' (Loeb, 1976).

Drug- treated

subjects were also found to possess decreased absolute
and relative adrenal weights as compared to saline
co~trol

subjects (Figures 3 and 9).

Thus, although

prednisolone depressed body weights, adrenal mass was
depressed at a faster rate.

Similar results have been

obtained with other glucocorticoids (Katz and Carroll,
1978; Kendall, 1970; Leshner, 1971; Salassa, Bennet,
Keating and Sprague, 1953).

It is well-known that
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continued high doses of exogenous glucocorticoids
generally suppress ACTH secretion via feedback inhibition mechanism(s)
Liddle, 1965).

(Graber, Ney, Nicholson, Island, and

Subsequent to ACTH suppression, adrenal

cortex undergoes atrophy, largely in the region of the
zone fasiculata (Haynes and Murad, 1980).
At what level(s) of the hypothalamo-pituitary axis
the glucocorticoids exert their ACTH suppressive effect
remains to be elucidated (Baxter and Forsham, 1972).
Glucocorticoid binding has been demonstrated in pituitary, hypothalamus, and other brain regions (McEwen,
1977).

Some evidence exists to suggest that the glu-

cocorticoids feed back to suppress secretion to the
so-called '31-K precursor' pro- hormone (Krieger,
Liotta, Brownstein, and Zimmerman, 1980).

Systemically

administered dexamethasone has been shown to decrease
beta-endorphin (component of precursor) content of the
pituitary (Guillemin, Vargo, Rossier, Minick, Ling,
Rivier, Vale and Bloom, 1977).

Further, depletion of

pituitary stores of endorphin via other procedures has
been shown to yield hyperalgesia.

For instance, hypo-

physectomy decreases the intensity of inescapeable shock
to which rats will respond (Gispen, Van Wimersma,
Greidanus, and DeWied, 1970).·

Thus, the tendency to-

wards hyperalgesia noted in the hot plate assay (Figure
4) may have been due to prednisolone's feedback in-
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hibition of the 31-K precursor.

Also relevant here are

the results of the avoidance study (Experiment No. 13),
in that this feedback inhibition might have altered
sensitivity to the gridfloor shock.

This plausibility

awaits analysis.
The data relating prednisolone to wheel running
activity revealed a direct, linear function which approached, but did not reach, statistical significance in
Experiment no. 1 (Figure 4).

That,some relation between

prednisolone administration and locomotion exists might
have been anticipated as various clinical reports of
'steroid psychosis' have detailed psychomotor agitation
in glucocorticoid- treated patients (Brown, 1962i Guynn,
1979i Haynes and Murad, 1980).

In addition, studies of

wheel running in rats receiving either replacement doses
of dexamethasone (Beatty, Scouten, and Beatty, 1971)
have demonstrated activity enhancement.

In those two

studies where dexamethasone was given (Beatty, Scouten,
and Beatty, 197li Kendall, 1970), wheel running was
enhanced to a degree greater than that reported in the
pr~sent

study for prednisolone.

At least.two possible

accounts of this difference may be offered.

First,

these two glucocorticoids may possess differing potencies with respect to locomotor stimulation.

Alternate-

ly, a procedural variable might be a crucial determinant
of across-reports diffferences.

In both (Beatty,
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Scouten, and Beatty, 19711 Kendall, 1970) previous
studies, many wheel running sessions were conducted
before and during glucocorticoid administration.

In

Experiment no. 1, only a single session was conducted.
It may be that the drug treatment interacts with previous history in the test apparatus to determine test
outcome.

Experiment no. 2 employed numerous, daily

wheel running test sessions and prednisolone was then
found to markedly enhance locomotor activity.

Taken to-

gether, the wheel running data of Experiments no. 1 and
2 do

suppo~t

the "drug treatment by Apparatus Exposure

interaction" hypothesis.
As noted, the glucocorticoids yield overall protein-wasting, resulting from both proteolysis and inhibition of protein synthesis.

As a consequence, mild

to dramatic wasting of skeletal muscle is common in
cases of both endogenous and iatrogenic Cushing's
syndrome (Nelson, 19801 Perko££, Silber, Tyler,
Cartwright, and Wintrobe, 1959).

As mentioned, our

gross postmortem carcass inspections revealed consi4erable absence of skeletal muscle in drug-treated
subjects.

In clinical cases such wasting is par-

ticularly marked in proximal regions of arms and legs
and may occur shortly after treatment initiation and be
severe enough to prevent ambulation (Haynes and Murad,
1980).

Thus, we had expected that prednisolone-treated
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subjects would have a much shorter latency to grasprelease upon elevated suspension than control subjects
so treated.

This result was not obtained, but rather,

as prednisolone dose increased, so too did latency to
grasp-response (Figure 4).
The determinants of this obtained relation are not
immediately obvious, though two possibilities suggest
themselves.

One is that the results of our 'wire test'

assay of grasping are the trivial consequences of decreased body mass.

Note that those groups with longest

latency to grasp- release were also those which weighed
least and thus had the least mass to support (note
Figure 4, Body Weight, Day 12).

Alternately, various

other investigations have shown exogenous glucocorticoid
treatment to alter passive avoidance.

It may be that

prednisolone-treated subjects retained grasp longer as a
result of an enhancement of those processes involved in
passive avoidance.

Glucocorticoids have generally been

shown however, to decrease passive avoidance performances (Bohus, 1973).

Further analysis of this effect upon

grasping responses will require appropriate weight control groups.
In the series of operant behavior experiments (Experiment nos. 4-13), acute prednisolone treatments were
found to be without substantial effect on steady-state
operant performances.

This was demonstrated for
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behavior maintained by variable interval, fixed-ratio,
and differential reinforcement of low rate schedules of
reinforcement.

This finding was shown to depend on

neither the pretreatment interval nor the type of appetitive reinforcer employed, nor the particular schedule in effect.

In contrast, repeated daily prednisolone

treatments did yield disruption of steady-state operant
performances, independent of the schedule of reinforcement.

This latter generalization was demonstrated not

to depend upon the type of appetitive reinforcer used,
nor the particular schedule of reinforcement.

The

present results are thus in accord with those various
clinical reports which indicate that only chronic, and
not acute, glucocorticoid treatments result in psychiatric disturbances (e.g. Guynn, 1979; Haynes and Murad,
1980; Ling, Perry and Tsuang, 1981).
Use of two daily sessions (pre- and post- drug
administration) in'the DRL experiment (Experiment no.
12) indicated that the disruption of operant performance
which follows repeated prednisolone exposure is only in
pa~t

drug.

the result of an increasing sensitization to the
Further, the prednisolone-induced gradual decay

in operant performance appears to be largely the result
of a steadily accuring behavioral debilitation.
Experiment no. 13 demonstrated that the ability to
acquire new operant behavior can also be altered as a
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function of repeated prednisolone treatment.

It remains

unclear, however, whether this effect on response acquisition is unique to aversively controlled responses or
whether positively reinforced responses are similarly
affected.
In summary, the present study demonstrated prednisolone as active in several behavioral assays employing rodents.

It is plausible that such assays may

be useful in subsequent studies attempting identification of selective antagonists of, and other drugs
interactive with, this agent.
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